5.00 score from hupso.pl for:
ghrp-2.us



HTML Content


Title apoptosis guide

Length: 16, Words: 2
Description pusty

Length: 0, Words: 0
Keywords pusty
Robots
Charset UTF-8
Og Meta - Title pusty
Og Meta - Description pusty
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 7448
Text/HTML 62.60 %
Headings H1 0
H2 20
H3 0
H4 0
H5 0
H6 0
H1
H2
apoptosis guide
porosity open and closed bulk density
gw841819x markov matrix of regional energy efficiency between and
venture capital entity industry green innovation introductionas the
effect size was calculated by dividing the between
as in case a the radiologist
figure options the follow up period was
competency in systems based practice although fruit
limitations of our study included
weight loss to evaluate the in vitro
falls status having multiple falls
the dinoprostone insert was left in situ for hours if
glutathione s-transferase v uv v uv v uv v uv v uv
collectively these data highlight the importance of providing counseling to
blogroll
recent posts
archives
categories
tags
meta
H3
H4
H5
H6
strong
|
|
|
|
|
|
|
|
|
|
|
|
|
b
i
em
Bolds strong 13
b 0
i 0
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 23
Pliki CSS 3
Pliki javascript 20
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 214
Linki wewnętrzne 0
Linki zewnętrzne 214
Linki bez atrybutu Title 155
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

pusty

Linki zewnętrzne

home http://www.ghrp-2.us/
http://www.ghrp-2.us/feed
купить аттестат о среднем http://bestdiplomi.com/attestat-11-klassov/
jailbreak ios 9.3 http://fastjailbreak.com/
   apr 09 http://www.ghrp-2.us/porosity-open-and-closed-bulk-density.html
porosity open and closed bulk density http://www.ghrp-2.us/porosity-open-and-closed-bulk-density.html
by admin http://www.ghrp-2.us/porosity-open-and-closed-bulk-density.html
ro3306 http://www.apexbt.com/ro-3306.html
energy http://www.journals.elsevier.com/energy/
uncategorized http://www.ghrp-2.us/category/uncategorized
691 comments » http://www.ghrp-2.us/porosity-open-and-closed-bulk-density.html#comments
   mar 25 http://www.ghrp-2.us/gw841819x-markov-matrix-of-regional-energy-efficiency-between-and.html
gw841819x markov matrix of regional energy efficiency between and http://www.ghrp-2.us/gw841819x-markov-matrix-of-regional-energy-efficiency-between-and.html
by admin http://www.ghrp-2.us/gw841819x-markov-matrix-of-regional-energy-efficiency-between-and.html
gw841819x http://www.apexbt.com/gw841819x.html
energy http://www.journals.elsevier.com/energy/
uncategorized http://www.ghrp-2.us/category/uncategorized
574 comments » http://www.ghrp-2.us/gw841819x-markov-matrix-of-regional-energy-efficiency-between-and.html#comments
   mar 25 http://www.ghrp-2.us/venture-capital-entity-industry-green-innovation-introductionas-the.html
venture capital entity industry green innovation introductionas the http://www.ghrp-2.us/venture-capital-entity-industry-green-innovation-introductionas-the.html
by admin http://www.ghrp-2.us/venture-capital-entity-industry-green-innovation-introductionas-the.html
gw841819x http://www.apexbt.com/gw841819x.html
energy http://www.journals.elsevier.com/energy/
uncategorized http://www.ghrp-2.us/category/uncategorized
28 comments » http://www.ghrp-2.us/venture-capital-entity-industry-green-innovation-introductionas-the.html#comments
   mar 25 http://www.ghrp-2.us/effect-size-was-calculated-by-dividing-the-between.html
effect size was calculated by dividing the between http://www.ghrp-2.us/effect-size-was-calculated-by-dividing-the-between.html
by admin http://www.ghrp-2.us/effect-size-was-calculated-by-dividing-the-between.html
ret pathway http://www.apexbt.com/research-area/apoptosis/c-ret.html
period http://en.wikipedia.org/wiki/period
inhibitors http://www.ghrp-2.us/category/inhibitors
ret pathway http://www.ghrp-2.us/tag/ret-pathway
no comments » http://www.ghrp-2.us/effect-size-was-calculated-by-dividing-the-between.html#respond
   mar 25 http://www.ghrp-2.us/as-in-case-a-the-radiologist.html
as in case a the radiologist http://www.ghrp-2.us/as-in-case-a-the-radiologist.html
by admin http://www.ghrp-2.us/as-in-case-a-the-radiologist.html
clinical trial remains http://www.apexbt.com/bx795.html
histamine http://en.wikipedia.org/wiki/histamine
inhibitors http://www.ghrp-2.us/category/inhibitors
clinical trial http://www.ghrp-2.us/tag/clinical-trial
no comments » http://www.ghrp-2.us/as-in-case-a-the-radiologist.html#respond
   mar 25 http://www.ghrp-2.us/figure-options-the-follow-up-period-was.html
figure options the follow up period was http://www.ghrp-2.us/figure-options-the-follow-up-period-was.html
by admin http://www.ghrp-2.us/figure-options-the-follow-up-period-was.html
s6 kinase http://www.apexbt.com/research-area/pi3k-akt-signaling/s6-kinase.html
heart http://en.wikipedia.org/wiki/heart
inhibitors http://www.ghrp-2.us/category/inhibitors
s6 kinase http://www.ghrp-2.us/tag/s6-kinase
no comments » http://www.ghrp-2.us/figure-options-the-follow-up-period-was.html#respond
   mar 25 http://www.ghrp-2.us/competency-in-systems-based-practice-although-fruit.html
competency in systems based practice although fruit http://www.ghrp-2.us/competency-in-systems-based-practice-although-fruit.html
by admin http://www.ghrp-2.us/competency-in-systems-based-practice-although-fruit.html
namely http://www.apexbt.com/romidepsin-fk228-depsipeptide.html
heart http://en.wikipedia.org/wiki/heart
inhibitors http://www.ghrp-2.us/category/inhibitors
namely http://www.ghrp-2.us/tag/namely
no comments » http://www.ghrp-2.us/competency-in-systems-based-practice-although-fruit.html#respond
   mar 25 http://www.ghrp-2.us/limitations-of-our-study-included.html
limitations of our study included http://www.ghrp-2.us/limitations-of-our-study-included.html
by admin http://www.ghrp-2.us/limitations-of-our-study-included.html
bafilomycin http://www.apexbt.com/search.php?catalog=a8627
heart http://en.wikipedia.org/wiki/heart
inhibitors http://www.ghrp-2.us/category/inhibitors
bafilomycin http://www.ghrp-2.us/tag/bafilomycin
no comments » http://www.ghrp-2.us/limitations-of-our-study-included.html#respond
   mar 25 http://www.ghrp-2.us/weight-loss-to-evaluate-the-in-vitro.html
weight loss to evaluate the in vitro http://www.ghrp-2.us/weight-loss-to-evaluate-the-in-vitro.html
by admin http://www.ghrp-2.us/weight-loss-to-evaluate-the-in-vitro.html
dopamine beta hydroxylase http://www.apexbt.com/research-area/metabolism/dopamine.html
antibodies http://www.biocompare.com/antibodies/
inhibitors http://www.ghrp-2.us/category/inhibitors
dopamine beta hydroxylase http://www.ghrp-2.us/tag/dopamine-beta-hydroxylase
no comments » http://www.ghrp-2.us/weight-loss-to-evaluate-the-in-vitro.html#respond
   mar 25 http://www.ghrp-2.us/falls-status-having-multiple-falls.html
falls status having multiple falls http://www.ghrp-2.us/falls-status-having-multiple-falls.html
by admin http://www.ghrp-2.us/falls-status-having-multiple-falls.html
wnt signaling pathway http://www.apexbt.com/research-area/stem-cell/wnt-signaling.html
s phase https://en.wikipedia.org/wiki/s_phase
inhibitors http://www.ghrp-2.us/category/inhibitors
wnt signaling pathway http://www.ghrp-2.us/tag/wnt-signaling-pathway
no comments » http://www.ghrp-2.us/falls-status-having-multiple-falls.html#respond
   mar 25 http://www.ghrp-2.us/the-dinoprostone-insert-was-left-in-situ-for-hours-if.html
the dinoprostone insert was left in situ for hours if http://www.ghrp-2.us/the-dinoprostone-insert-was-left-in-situ-for-hours-if.html
by admin http://www.ghrp-2.us/the-dinoprostone-insert-was-left-in-situ-for-hours-if.html
low-dose serine protease http://www.apexbt.com/research-area/proteases/serine-protease.html
zone of elongation http://wiki.answers.com/q/what_is_the_zone_of_elongation_of_a_root_in_a_plant
inhibitors http://www.ghrp-2.us/category/inhibitors
serine protease http://www.ghrp-2.us/tag/serine-protease
no comments » http://www.ghrp-2.us/the-dinoprostone-insert-was-left-in-situ-for-hours-if.html#respond
   mar 25 http://www.ghrp-2.us/glutathione-s-transferase-v-uv-v-uv-v-uv-v-uv-v-uv.html
glutathione s-transferase v uv v uv v uv v uv v uv http://www.ghrp-2.us/glutathione-s-transferase-v-uv-v-uv-v-uv-v-uv-v-uv.html
by admin http://www.ghrp-2.us/glutathione-s-transferase-v-uv-v-uv-v-uv-v-uv-v-uv.html
glutathione s-transferase http://www.apexbt.com/research-area/others/gutathione-s-transferase.html
resolution http://en.wikipedia.org/wiki/resolution
inhibitors http://www.ghrp-2.us/category/inhibitors
glutathione s-transferase http://www.ghrp-2.us/tag/glutathione-s-transferase
no comments » http://www.ghrp-2.us/glutathione-s-transferase-v-uv-v-uv-v-uv-v-uv-v-uv.html#respond
   mar 24 http://www.ghrp-2.us/collectively-these-data-highlight-the-importance-of-providing-counseling-to.html
collectively these data highlight the importance of providing counseling to http://www.ghrp-2.us/collectively-these-data-highlight-the-importance-of-providing-counseling-to.html
by admin http://www.ghrp-2.us/collectively-these-data-highlight-the-importance-of-providing-counseling-to.html
tozadenant http://www.apexbt.com/tozadenant.html
population http://en.wikipedia.org/wiki/population
inhibitors http://www.ghrp-2.us/category/inhibitors
tozadenant http://www.ghrp-2.us/tag/tozadenant
no comments » http://www.ghrp-2.us/collectively-these-data-highlight-the-importance-of-providing-counseling-to.html#respond
1 http://www.ghrp-2.us/
2 http://www.ghrp-2.us/page/2
3 http://www.ghrp-2.us/page/3
4 http://www.ghrp-2.us/page/4
5 http://www.ghrp-2.us/page/5
>> http://www.ghrp-2.us/page/2
ghrp 6 http://www.ghrp-6.us/simi-larly.html
effect size was calculated by dividing the between http://www.ghrp-2.us/effect-size-was-calculated-by-dividing-the-between.html
as in case a the radiologist http://www.ghrp-2.us/as-in-case-a-the-radiologist.html
figure options the follow up period was http://www.ghrp-2.us/figure-options-the-follow-up-period-was.html
competency in systems based practice although fruit http://www.ghrp-2.us/competency-in-systems-based-practice-although-fruit.html
limitations of our study included http://www.ghrp-2.us/limitations-of-our-study-included.html
march 2017 http://www.ghrp-2.us/2017/03
february 2017 http://www.ghrp-2.us/2017/02
january 2017 http://www.ghrp-2.us/2017/01
december 2016 http://www.ghrp-2.us/2016/12
november 2016 http://www.ghrp-2.us/2016/11
october 2016 http://www.ghrp-2.us/2016/10
september 2016 http://www.ghrp-2.us/2016/09
august 2016 http://www.ghrp-2.us/2016/08
july 2016 http://www.ghrp-2.us/2016/07
june 2016 http://www.ghrp-2.us/2016/06
may 2016 http://www.ghrp-2.us/2016/05
april 2016 http://www.ghrp-2.us/2016/04
march 2016 http://www.ghrp-2.us/2016/03
february 2016 http://www.ghrp-2.us/2016/02
january 2016 http://www.ghrp-2.us/2016/01
december 2015 http://www.ghrp-2.us/2015/12
november 2015 http://www.ghrp-2.us/2015/11
october 2015 http://www.ghrp-2.us/2015/10
september 2015 http://www.ghrp-2.us/2015/09
august 2015 http://www.ghrp-2.us/2015/08
july 2015 http://www.ghrp-2.us/2015/07
june 2015 http://www.ghrp-2.us/2015/06
may 2015 http://www.ghrp-2.us/2015/05
april 2015 http://www.ghrp-2.us/2015/04
march 2015 http://www.ghrp-2.us/2015/03
february 2015 http://www.ghrp-2.us/2015/02
january 2015 http://www.ghrp-2.us/2015/01
december 2014 http://www.ghrp-2.us/2014/12
november 2014 http://www.ghrp-2.us/2014/11
october 2014 http://www.ghrp-2.us/2014/10
september 2014 http://www.ghrp-2.us/2014/09
august 2014 http://www.ghrp-2.us/2014/08
july 2014 http://www.ghrp-2.us/2014/07
june 2014 http://www.ghrp-2.us/2014/06
april 2014 http://www.ghrp-2.us/2014/04
august 2013 http://www.ghrp-2.us/2013/08
july 2013 http://www.ghrp-2.us/2013/07
june 2013 http://www.ghrp-2.us/2013/06
may 2013 http://www.ghrp-2.us/2013/05
april 2013 http://www.ghrp-2.us/2013/04
march 2013 http://www.ghrp-2.us/2013/03
february 2013 http://www.ghrp-2.us/2013/02
january 2013 http://www.ghrp-2.us/2013/01
september 2012 http://www.ghrp-2.us/2012/09
inhibitors http://www.ghrp-2.us/category/inhibitors
uncategorized http://www.ghrp-2.us/category/uncategorized
2-methoxyestradiol http://www.ghrp-2.us/tag/2-methoxyestradiol
3x flag peptide http://www.ghrp-2.us/tag/3x-flag-peptide
acth 1-39 http://www.ghrp-2.us/tag/acth-1-39
aod9604 http://www.ghrp-2.us/tag/aod9604
buy hgh frag 176-191 http://www.ghrp-2.us/tag/buy-hgh-frag-176-191
buy thymosin beta 4 http://www.ghrp-2.us/tag/buy-thymosin-beta-4
ca 074 http://www.ghrp-2.us/tag/ca-074
cjc 1293 http://www.ghrp-2.us/tag/cjc-1293
cjc 1295 http://www.ghrp-2.us/tag/cjc-1295
cjc 1295 with dac http://www.ghrp-2.us/tag/cjc-1295-with-dac
cjc 1295 without dac http://www.ghrp-2.us/tag/cjc-1295-without-dac
c myc peptide http://www.ghrp-2.us/tag/c-myc-peptide
dsip http://www.ghrp-2.us/tag/dsip
e 64d http://www.ghrp-2.us/tag/e-64d
follistatin 344 http://www.ghrp-2.us/tag/follistatin-344
ghrp-2 http://www.ghrp-2.us/tag/ghrp-2
ghrp 6 http://www.ghrp-2.us/tag/ghrp-6
ha tag http://www.ghrp-2.us/tag/ha-tag
hexa his http://www.ghrp-2.us/tag/hexa-his
hexarelin http://www.ghrp-2.us/tag/hexarelin
hgh frag 176-191 http://www.ghrp-2.us/tag/hgh-frag-176-191
igf 1 des http://www.ghrp-2.us/tag/igf-1-des
igf 1 lr3 http://www.ghrp-2.us/tag/igf-1-lr3
ipamorelin http://www.ghrp-2.us/tag/ipamorelin
jq1 http://www.ghrp-2.us/tag/jq1
mechano growth factor http://www.ghrp-2.us/tag/mechano-growth-factor
melanotan i http://www.ghrp-2.us/tag/melanotan-i
melanotan ii http://www.ghrp-2.us/tag/melanotan-ii
myostatin human propeptide http://www.ghrp-2.us/tag/myostatin-human-propeptide
peg mgf http://www.ghrp-2.us/tag/peg-mgf
phos-tag http://www.ghrp-2.us/tag/phos-tag
phos-tag acrylamide http://www.ghrp-2.us/tag/phos-tag-acrylamide
pr-047 http://www.ghrp-2.us/tag/pr-047
ps 341 http://www.ghrp-2.us/tag/ps-341
pt 141 http://www.ghrp-2.us/tag/pt-141
q-vd-oph http://www.ghrp-2.us/tag/q-vd-oph
sermorelin http://www.ghrp-2.us/tag/sermorelin
snap 8 http://www.ghrp-2.us/tag/snap-8
s tag http://www.ghrp-2.us/tag/s-tag
sw033291 http://www.ghrp-2.us/tag/sw033291
t7 tag http://www.ghrp-2.us/tag/t7-tag
tb500 http://www.ghrp-2.us/tag/tb500
tesamorelin http://www.ghrp-2.us/tag/tesamorelin
thymosin beta 4 http://www.ghrp-2.us/tag/thymosin-beta-4
z-vad-fmk http://www.ghrp-2.us/tag/z-vad-fmk
log in http://www.ghrp-2.us/wp-login.php
entries rss http://www.ghrp-2.us/feed
comments rss http://www.ghrp-2.us/comments/feed
wordpress.org https://wordpress.org/
© 2017 apoptosis guide http://www.ghrp-2.us/
adazing web design http://www.adazing.com/

Zdjęcia

Zdjęcia 8
Zdjęcia bez atrybutu ALT 2
Zdjęcia bez atrybutu TITLE 8
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

http://www.labpe.net/img2/an4966.gif
http://www.apexbt.com//media/diy/images/struct/a4138.png#
http://www.labpe.net/img2/an2070.gif
http://www.apexbt.com//media/diy/images/struct/a4133.png#
http://www.labpe.net/img2/an3992.gif
http://www.labpe.net/img2/an0376.gif
http://www.labpe.net/img2/an5656.gif
http://www.labpe.net/img2/an1624.gif

Zdjęcia bez atrybutu ALT

http://www.apexbt.com//media/diy/images/struct/a4138.png#
http://www.apexbt.com//media/diy/images/struct/a4133.png#

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

apoptosis guide papers about apoptosis,fas c- terminal tripeptide,z-vad-fmk home купить аттестат о среднем jailbreak ios 9.3 apr 09 porosity open and closed bulk density by admin characterization of sintered discs containing distinct sawdust content in the bottom-layer obtained from mercury intrusion porosimetry.sawdust content (wt.%)open porosity (%)bulk density (g/cm3)median pore diameter (μm)2.54.82.301.255.42.2415.81011.12.1640.8full-size tabletable optionsview in workspacedownload as csvfig. 6. pore size distribution curves (calculated from mercury intrusion data) for sintered discs produced with distinct sawdust content.figure optionsdownload full-size imagedownload as powerpoint slideto comply with the standard, porcelain stoneware tiles must have bending strength values higher than 35 mpa (iso 10545/4). in this work, the mechanical resistance of the sintered bi-layered ceramic discs is controlled by the degree of porosity in the bottom-layer of the discs. fig. 7 presents the bending strength and young\’s modulus of the fired bodies. results show that both parameters diminish with increasing sawdust content. nevertheless, the incorporation of up to 10 wt% of sawdust creates materials that still comply with these specifications. as for other standard properties required for porcelain stoneware tiles they ro3306 are ensured by the dense top-layer.fig. 7. mechanical properties of bi-layered ceramic tiles as a function of sawdust content: (a) bending strength and (b) young\’s modulus.figure optionsdownload full-size imagedownload as powerpoint slidethe specific strength of samples was also evaluated, as proposed by ashby (2005). experimental values ranged between 3.2 and 4.0 mpa0.5 cm3/g, being similar to those reported in the literature for lightweight porcelain stoneware tiles (bernardo et?al., 2010 and novais et?al., 2014).the creation of porosity in the bottom layer sintered discs is expected to decrease the thermal conductivity of the bodies. in fact, the thermal conductivity strongly decreases with porosity, as shown in fig. 8. for comparison purposes, the thermal conductivity of a standard ceramic sample (prepared without porogen addition) was included in the figure. a threefold decrease in the thermal conductivity (from 0.71 to 0.23 w/m k) was observed when only 5 wt% sawdust was added to the bottom layer of the bi-layered discs. this observation is consistent with the above-mentioned porogen percolation threshold. indeed, sem micrographs in fig. 5b and f clearly show the formation of networks between adjacent pores, hence reducing the solid paths throughout the ceramic body. the thermal conductivity attenuation with porosity level observed in fig. 8 was steeper than that observed when polypropylene and polymethyl methacrylate were used as porogen agents (novais et al., 2014). the thermal insulation achieved with sawdust incorporation endows porcelain stoneware ceramic tiles with new features that may extend the range of applications of this common product.fig. 8. thermal conductivity of the porous layer sintered discs, prepared with sawdust, as function of open porosity level. the horizontal line corresponds to the thermal conductivity of a standard composition (without porogen).figure optionsdownload full-size imagedownload as powerpoint slide4. conclusionsthis study evaluated the possibility of using wood wastes (sawdust) as a pore forming agent for producing porcelain stoneware ceramic tiles with novel features.lightweight bi-layered bodies showing suitable mechanical resistance and low thermal conductivity were fabricated, attesting to the potential of using sawdust as a pore forming agent in such fast-fired ceramic products.optical microscopy and mercury intrusion porosimetry characterization demonstrated that the porosity level is controlled by sawdust content, and therefore can be tuned considering the application envisaged.sawdust presents fast and complete combustion, without leaving residues or ashes, and does not induce defects in the ceramics bodies. additionally, the heat released from its decomposition brings value to the ceramic tile manufacturing process, allowing energy savings.the incorporation of sawdust in the bottom layer of the bi-layered ceramics promotes weight reduction (up to 7.5%) and simultaneous thermal conductivity attenuation (up to 76%). the low porogen percolation threshold (5 wt%) achieved endorsed a threefold decrease in the ceramic tile\’s thermal conductivity in comparison to commercial stoneware tiles. at the same time, the product complies with mechanical strength requirements when sawdust incorporation level is below 10 wt%.results demonstrate that innovative products with excellent features can be produced by incorporation of sawdust into porcelain stoneware ceramic tiles. the novel ceramic tiles ensure environmental, technical and economic advantages: waste valorisation by sawdust reuse (environmental advantage); density reduction of the product which decreases the tiles transportation and distribution costs (economic advantage); restrain energy loss (technical advantage). these new and exciting features may widen the range of applications of porcelain stoneware tiles while simultaneously contributing towards sustainable construction.acknowledgementsthe authors acknowledge the financial support from portuguese innovation agency (adi) through project thermocer, to ciceco (pest c/ctm/la0011/2013) and rnme – pole university of aveiro (fct project rede/1509/rme/2005) for instrument use, scientific and technical assistance. the authors acknowledge cinca for providing the spray-dried powder, and the assistance of dr. r.c. pullar with editing english language in this paper. posted in uncategorized | 691 comments » mar 25 gw841819x markov matrix of regional energy efficiency between and by admin venture capital; entity industry; green innovation1. introductionas the important foundation of national economy, entity industry refers to real industry satisfying material and cultural needs of human, including agriculture, manufacturing and most service industries. entity industry can be divided into green industry and non-green industry from the perspective whether it is conducive to resource conservation and environmental protection. green industry is conducive to resource conservation and environmental protection. narrow-sense green industry refers to service industry of gw841819x conservation and environmental management services, while general green industry is the industry consuming less resource and producing less environmental pollution. the so-called non-green industry refers to industries with large consumption of resources and heavy environmental pollution.green innovation refers to technological innovation that ecological concept is introduced into various stages of technological innovation for entity industry, thus benefiting resource conservation and environmental protection (zhang, 2013). practice in developed countries has proved its important supporting role in energy conservation. for example, the use of aeration technology played a huge role in the pollution control project of uk thames in early 1960s. in 1970s, japan introduced the world’s most stringent standards of sulfur dioxide emission, greatly reducing sulfur dioxide emissions through desulfurization technology (bu, 2006).the support of financial industry is indispensable to promote green innovation activities. it is reasonable and necessary for government to provide financial supports due to significant positive externalities of green innovation. however, financial resources form government is very limited compared to the fund demand of green innovation. after all, aspects of response to climate change, pollution control, eco-economy development, and sustainable development are common aspiration of mankind throughout the world. it is the inevitable trend of economic and social development to transform economic development mode and lifestyle with construction of ecological civilization. thus, expansion of green innovation funding sources has become an inevitable choice for entity industries. according to the prediction of us energy foundation and china national development and reform commission, annual financing gap of chinese energy saving industry, new energy industry and environmental management industry is about 200 billion rmb; it will reach at least two trillion rmb by 2020 (subject group, 2009). therefore, industries of energy conservation, new energy development and environmental management cannot be promoted for green innovation without active use of financial instruments, thus making it difficult to promote green innovation.academic research has proved the supporting role of venture capital in technology innovation. kortum and lerner (2000) found that venture capital greatly promoted technology innovation in economy in the united states – the promoting effect of 1 posted in uncategorized | 574 comments » mar 25 venture capital entity industry green innovation introductionas the by admin spatial markov matrix of regional gw841819x efficiency between 1999 and 2010 in china.spatial lagti/ti+1n1: <75%2: <100%3: <125%4: >125%11200.950.050.000.002120.050.860.090.00340.000.001.000.00400.000.000.000.0021650.900.080.000.022560.050.850.090.013290.000.150.780.074180.000.000.180.8231121.000.000.000.002150.000.690.310.003390.000.190.700.114180.000.050.140.814100.000.000.000.00200.000.000.000.003140.000.000.800.204580.000.000.030.97full-size tabletable optionsview in workspacedownload as csvtable 5 illustrates three factors.first, the spatial relationship between regions plays an important role in the convergence club of energy efficiency in china. with different neighbors, the transition probabilities of regional energy are different. in other words, if the background of a region does not change, the four conditional matrices in the same period in table 5 should be similar to each other. in fact, the background of a region does not change.second, different regional backgrounds play different roles in the transfer of energy efficiency type. the probability of an upward shift will increase and the probability of a downward shift will decrease if a region is within the regional neighborhood with a high level of energy efficiency. conversely, the probability of an upward shift will decrease and the probability of a downward shift will increase if a region is within the regional neighborhood with a low level of energy efficiency. between 1999 and 2010, when a region with low energy efficiency is adjacent to regions with low energy efficiency, the probability of an upward shift is 5%; meanwhile, if a region is adjacent to regions with medium-low, medium-high, or high-level energy efficiency, the upward shift probability is increased to 8%. the probability of an upward shift is 19%, and the probability of a downward shift is 10% if a region with medium-low energy efficiency is adjacent to regions with low or medium-low energy efficiency; the probability of an upward shift is 31% and the probability of a downward shift is 0% if a region is adjacent to regions with medium-high or high energy efficiency. when a region with medium-high energy efficiency is adjacent to regions with low, medium-low, or medium-high energy efficiency, the probability of an upward shift is 11% and the probability of a downward shift is 34%; meanwhile, if a region is adjacent to regions with high or medium-high energy efficiency, the probability of an upward shift is 20% and the probability of a downward shift is 0%. when a region with high energy efficiency is adjacent to regions with lower energy efficiency, the probability of a downward shift is 32%; meanwhile, if a region is adjacent to regions with higher energy efficiency, the probability of a downward shift is 3%.third, the matrix of the spatial markov transition probability provides a spatial interpretation for the “club convergence” phenomenon. a region will be negatively influenced by its geographical neighbors with a low level of energy efficiency. between 1999 and 2010, if the geographical neighbors of a region have a low level of energy efficiency, the probability of this region to maintain a low level of energy efficiency after several years is 95%. this probability is higher than the probability that ignores the regional neighbors in table 4, which is 0.92 in the same period. between 1999 and 2010, the probability of a region to maintain a high level of energy efficiency is 97% if its geographical neighbors are at a high level as well; this probability is higher than the probability in table 4 in the same period, which is 0.90.4. conclusionwe adopt dea in this paper to calculate regional energy efficiency from the perspective of total-factor energy efficiency, and the club convergence of the regional energy efficiency in china is subsequently tested using the markov chain and spatial markov chain methods. we draw the following conclusions:(1)the “club convergence” phenomenon exists in the regional energy efficiency in china between 1999 and 2010, and the levels of club convergence are low, medium-low, medium-high, and high. moreover, the stability of both low- and high-level club convergence is high.(2)the energy efficiency class transitions in china are highly constrained by their regional backgrounds. the regional transitions are positively influenced by regions with a high level of energy efficiency and are negatively influenced by regions with a low level of energy efficiency. these empirical analyses provide a spatial explanation to the existence of the “club convergence” phenomenon of regional energy efficiency in china.(3)in accordance with the dynamic evolution of regional energy efficiency in china, special attention should be paid to spatial effect, and regional cooperation should be strengthened. policy that favors the “enrich the neighbor” approach should be used in regions with a high level of energy efficiency. simultaneously considering the geography, population, industry, resources, etc., attains a win–win situation on energy efficiency. preferential policies should be implemented in the low-level and low-growth regions of energy efficiency to enhance the opening-up level, thus accelerating the adjustment and optimization of the industrial structure, and the promotion of energy efficiency of these areas.acknowledgementsthis paper is the stage achievement of the national natural science foundation of china (71303029) and the national social science fund project (10bgl066). the author is grateful for the support of the national natural science foundation of china and the national social science foundation of china. posted in uncategorized | 28 comments » mar 25 effect size was calculated by dividing the between by admin effect size was calculated by dividing the between-group difference in linear mixed models by the unadjusted pooled standard deviation of the difference between post- and preintervention values. to account for possible bias introduced by missing values, multiple imputation sensitivity analyses were performed. fifteen imputed datasets were generated using predictors based on baseline variables that ret pathway were (1) adjustments or outcome variables in the model, (2) associated (r > 0.3) with outcomes, or (3) associated (r > 0.3) with categorical causes for missing values.24 the multiple imputation models were sequentially conducted for each follow-up. imputations were constricted dependent on causes for missing values; when caused by physical impairment, maximum imputed values was limited to the lowest observed value, while when caused by the participants’ being dead no values were imputed. all analyses were performed using ibm spss statistics for macintosh version 21.0 (ibm corp, armonk, ny) and r version 3.2.2 (r core team, vienna, austria) software. all statistical tests were 2-tailed and p values of period was 73% in the exercise group and 70% in attention control group. strength exercises were performed at moderate or high intensity (for 76% of attended sessions) and balance exercises at high intensity (for 75% of attended sessions).16 participant characteristics and outcome measures at baseline characteristics total exercise control dementia type diagnoses and medical conditions prescription medication assessments usual mobility device outcome measures gs, gait speed with habitual walking aid if any; gs-nowa, gait speed without walking aid and with minimum support. values are mean ± sd or n (%). numbers reported after covariates indicate number of measurements available when values were missing. higher scores indicate better status. lower scores indicate better status. table options outcomes within- and between-group differences from baseline in gs and gs-nowa measures within-group differences between-group differences icc? n n p value gs gs-nowa ci, confidence interval; icc, intracluster correlation coefficient; n, number of participants with complete data; se, standard error; gs, gait speed with habitual walking aid if any; gs-nowa, gait speed without walking aid and with minimum support. posted in inhibitors , ret pathway | no comments » mar 25 as in case a the radiologist by admin as in case a, the radiologist is not making cancer treatment recommendations but provides timely referrals to specialties for treatment decisions. addressing challenges of cancer care delivery and teamwork: the 4r approach the challenges described and illustrated here present barriers to systematic rigorous teamwork, undermine cancer patient engagement, cause care breakdowns, and result in suboptimal course of treatment. these issues are further exacerbated when a patient obtains care from multiple institutions or practices, which is common in oncology 7 and 43. however, these issues are not unique to oncology or health care; a vast array of modern industries depend on rigorous, systematic teamwork, from construction and it to fashion design. one of the disciplines broadly and successfully used to manage complex, multidisciplinary teamwork is project management 44, 45 and 46. although its use in care delivery has been proposed 38, 47 and 48, it clinical trial remains underused in this context. project management is uniquely suited to manage teamwork in oncology [23]. it inherently addresses the four care delivery challenges highlighted previously (table 1). it provides a systematic, yet flexible approach to structuring teamwork and adapting to different care settings and environments. also, it is familiar to many patients from their line of work and to many providers from institutional quality improvement projects 32 and 49. we previously proposed the 4r approach to facilitate rigorous, patient-centric teamwork in oncology, leveraging the project management discipline 23, 30 and 38 (table 1). under histamine approach, care for a cancer patient is managed as a project, using a care project plan (“care sequence”), which specifies the timing and sequencing of interdependent care events across clinical domains relevant to the patient’s care. a quarterback function is established as a tandem of a physician and a nurse. the quarterback function creates the care sequence from a predeveloped template for a newly diagnosed patient and identifies the 4r care team, which will use the care sequence in the process of care delivery. within the quarterback function, the physician determines clinical recommendations and/or referrals to relevant specialties to be included in the care sequence and serves as an ongoing physician resource for the patient (eg, to resolve conflicting clinical recommendations across specialties). the nurse facilitates the development of the care sequence, working with the physician and patient, and organizes patient care according to the sequence. this includes engaging members of the care team at the “right” time and in the “right” sequence, and updating the care sequence if needed. many institutions employ a patient nurse navigator who helps a patient with breast cancer follow her care plan across different specialties once a plan is established but typically does not devise the care plan. in the 4r model, a navigator could also assume the responsibility of the nurse who works with the quarterback physician and patient to devise the care sequence as the patient care project plan. posted in inhibitors , clinical trial | no comments » mar 25 figure options the follow up period was by admin figure options the follow-up s6 kinase was defined from the index date until the first occurrence of aki or the end date of the study period (december 31, 2013), whichever came first. the outcome of aki was defined as those who received a diagnosis coded as icd-9-cm 580.x, 584.x, or 586 during hospitalization or during at least 1 outpatient visit. the validation of icd-9-cm codes for identifying aki was performed previously, and the positive predictive value of aki was 0.96 compared with the clinical diagnosis of aki based on the acute kidney injury network criteria 11 and 12. the definition of aki using the acute kidney injury network criteria was an absolute increase in serum creatinine of ≥0.3 mg/dl, a percentage increase in serum creatinine of ≥50%, or a reduction in urine output (documented oliguria of sensitivity = [tp / (tp + fn)], specificity = [tn / (tn + fp)], positive predictive value = [tp / (tp + fp)], and negative predictive value = [tn / (tn + fn)], where tp is true positive, tn is true negative, fp is false positive, and fn is false negative. covariates risk factors for kidney injury, including age, comorbidities, previous bleeding history, and medication history, such as use of nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, aminoglycoside, and steroids at baseline, were referenced to any claim record with the previously mentioned diagnoses or medication codes before the index date. a specific medication history was confined to at least 1 prescription within 3 months preceding the index date. a bleeding history was confined to events within 6 months preceding the index date (15). the cha2ds2-vasc score was calculated based on the summation of the following risk factors: 2 points for age 75 years or older or previous stroke/transient ischemic attack and 1 point each for congestive heart failure, hypertension, diabetes mellitus, vascular disease, age 65 to 74 years, and female sex (15). the has-bled score was calculated according to the summation of the following risk factors (1 point for each risk factor if present): hypertension, abnormal renal and liver function, stroke, prior major bleeding, labile international normalized ratios (inrs), age 65 years or older, and history of drug or alcohol use (15). posted in inhibitors , s6 kinase | no comments » mar 25 competency in systems based practice although fruit by admin competency in systems-based practice: although fruit, vegetables, and whole grain cereals are part of dietary advice given internationally, foods containing soy protein, nuts, viscous fiber sources (oats, barley, psyllium), and plant sterols (e.g., as in enriched margarine) have been approved by the u.s. food and drug administration for namely health claims since they specifically lower serum cholesterol. translational outlook: dietary change is difficult in relatively healthy populations and may take community-based strategies to implement effectively, but even limited patient instructions, including pamphlets and guidelines from national public health agencies may lead to reductions in body weight and coronary heart disease risk scores. appendix electronic file online data online data. help with pdf files options abbreviations and acronyms bmi, body mass index; chd, coronary heart disease; ckb, china kadoorie biobank; cvd, cardiovascular disease; ihd, ischemic heart disease; is, ischemic stroke; mce, major coronary events; whr, waist-to-hip ratio ischemic heart disease (ihd) and ischemic stroke (is) are posing major burdens to global health (1), and they are the leading causes of death in china (2). although pharmacological treatment has shown considerable effectiveness in improving therapy of these diseases, it is costly and may have side effects. in contrast, adherence to a healthy lifestyle has become a mainstream approach to lower cardiovascular burden through primary prevention (3). in epidemiological studies, modifiable lifestyle factors, such as nonsmoking (4), moderate alcohol consumption (5), physical activity (6), healthy diets 7 ; 8, and low adiposity 9 ; 10, have been consistently linked to a reduced cardiovascular risk. several previous studies showed that adherence to a healthy lifestyle defined by a combination of these modifiable factors was related to up to roughly an 80% reduction in coronary heart disease (chd) incidence 11; 12; 13 ; 14, and a 50% reduction in is incidence (15), in white populations from developed countries. however, little is known whether such protective effects persist in other nonwhite populations like the asian population. we thus aimed to examine the associations of a combination of modifiable, healthy lifestyle factors with the risks of ihd and is in a large cohort of 0.5 million of adult chinese: the china kadoorie biobank (ckb) study (16). in addition, we estimated the proportion of ischemic cardiovascular diseases (cvds) that could potentially be prevented by adherence to the healthy lifestyle patterns. methods study population the ckb cohort was established in 10 study areas geographically spread across china during 2004 to 2008, when all nondisabled, permanent residents of each area who were 35 to 74 years of age were invited to participate in the study. of the total of approximately 1.8 million eligible adults in these areas, almost 1 in 3 (33% in rural areas and 27% in urban areas) responded (17). overall, 512,891 adults 30 to 79 years of age were enrolled in the study, including a few who were just outside the targeted age range. all participants had completed a questionnaire, had physical measurements taken, and had completed a written informed consent form. the ethical review committee of the chinese center for disease control and prevention (beijing, china) and the oxford tropical research ethics committee at the university of oxford (oxford, united kingdom) approved the study. further details of the ckb cohort have been described in previous publications 16 ; 17. posted in inhibitors , namely | no comments » mar 25 limitations of our study included by admin limitations of our study included: small number of patients that may be attributed to the rarity of pe; no comparison with adult or children patient group; and no comparison with patients undergoing minimally invasive approach (nuss procedure) as it is not available in our institution. 5. conclusion in conclusion, satisfactory clinical and cosmetic results were observed during early and mid-term periods after open repair of moderate to severe pe using prolene? polypropylene mesh for sub-sternal support in adolescents, avoiding extensive removal of the deformed cartilages. further large size, long-term and comparative studies are recommended. funding sources none. conflicts of interest none. 1. introduction pulmonary alveolar proteinosis (pap) is a rare disease described first by rosen and associates in 1958 [1] and is characterized by accumulation of surfactant lipoproteins within the bafilomycin that can end up in respiratory failure due to impaired oxygen transfer across the alveoli [2]. recent investigations achieved a revolution in understanding the mechanisms that lead to the development of pap and showed that the most effective method of its treatment is the mechanical removal of surfactant material from the alveoli. whole lung lavage (wll) represents now the treatment of choice for pap in many centers [3]. alternatively bronchoscopic lobar lavage (bll) using fiberoptic bronchoscopy under local anesthesia or rigid bronchoscopy under general anesthesia is still used by some centers. multiple fiberoptic bronchoscopic lavage offers a limited volume of lavage fluid and may be associated with were severe cough and hypoxemia [4]. this is a retrospective study to compare the outcome of wll with that of bll using the rigid bronchoscope, in patients with pap. 2. patients and methods 2.1. techniques 2.1.1. bronchoscopic lobar lavage under general anesthesia, muscle relaxation and intermittent venturi ventilation with standard monitoring of heart rate, blood pressure, and repeated arterial blood gases, the rigid bronchoscope was wedged into the right main and then left main bronchi. about 8–10 l of warm normal saline solution was injected via a 50 ml syringe through the bronchoscope in each bronchus sequentially and then suctioned with a catheter. 2.1.2. whole lung lavage under general anesthesia and muscle relaxation using double lumen lung ventilation with standard monitoring of heart rate, blood pressure, and frequent arterial blood gases. measures of expiratory volume and inspiratory airway pressure were recorded as an indicator of prelavage lung compliance. both lungs were ventilated first at fio2 100%. then the cuffs of the double lumen tube were inflated separately, and the tube was tested for leaks to ensure complete separation of both lungs. a bout 3 l of sterile physiological saline solution (lavage solution) warmed to 37 °c were allowed to run by gravity into the more affected lung through one arm of a y-tube from a height of 30 cm above the patient\’s mid-chest, while the other lung being continuously ventilated with the high oxygen-content air. when the saline had almost completely replaced air in the lavaged lung and this lung had been degassed, the inflow limb of the y-tube was clamped, and other arm of this tube was inserted into an empty bottle approximately 20 cm below the patient. cloudy effluent fluid drained rapidly by gravity and siphon effect out of the lavaged lung. however a volume comparable to the patient\’s functional residual capacity (30 ml/kg) was left in the lung after this initial filling to prevent hydrostatic alveolar pressure from dropping to low levels during draining, thus avoiding hypoxemia resulting from increased perfusion pressure of a non-ventilated lung. manual chest percussion was performed during the filling and draining of the lavaged lung. at the end of the drainage process, the outflow limb of the y-tube was clamped and the inflow limb was declamped to rapidly refill the lavaged lung again. the process of refilling and draining was repeated rapidly with only 500 ml until the effluent comes out almost clear. volumes exchanged were recorded each time. in the average 15 l up to 18 l of normal saline were needed till the effluent fluid became clear. posted in inhibitors , bafilomycin | no comments » mar 25 weight loss to evaluate the in vitro by admin weight loss to evaluate the in vitro bioactivity, the pcl/β-tcp composites were immersed in a 10-ml simulated body fluid (sbf) solution at 37°c. the sbf solution, of which the ionic composition is similar to that of human blood plasma, consisted of 7.9949 g of nacl, 0.3528 g of nahco3, 0.2235 g of kcl, 0.147 g of k2hpo4, 0.305 g of mgcl2-6h2o, 0.2775 g of cacl2, and 0.071 of g na2so4 in 1000 ml of distilled h2o and was buffered to a ph of 7.4 with hydrochloric dopamine beta hydroxylase (hcl) and trishydroxymethyl aminomethane (ch2oh3cnh2).16 all chemicals used were of reagent grade. the solution in the shaker water bath exhibited no change under static conditions. after soaking for different time durations (from 3 days to 3 months), specimens were removed from the tube and evaluated for various physicochemical properties. the degree of degradation was determined by monitoring the weight change of the specimens. after drying at 45°c, the composites were weighed using a balance both before and after immersion. the 10 specimens were examined at each time point for each of the materials being investigated. mechanical properties after being taken out of the mold, the specimens were incubated at 37°c in 100% humidity for 1 day. diametral tensile strength (dts) testing was conducted on an ez-test machine (shimadzu, kyoto, japan) at a loading rate of 1 mm/min. the maximum compression load at failure was obtained from the recorded load-deflection curves. cell adhesion and proliferation before performing the cell experiments, all samples were sterilized by being soaked in 75% ethanol and then exposed to uv light for 30 minutes. the hbmscs were obtained from sciencell research laboratories (sciencell, carlsbad, ca, usa) and grown in mesenchymal stem cell medium (sciencell) at passage 3–6. the hbmscs were directly cultured on the sterilized specimens at a density of 104 cells per well in a 24-well plate and incubated at 37°c in a 5% co2 atmosphere for various numbers of days. after different culturing times, cell viability was evaluated using the prestoblue (invitrogen, grand island, ny, usa) assay. at the end of the culture period, the medium was discarded and the wells were washed twice with cold phosphate-buffered saline (pbs). each well was then filled with a 1:9 ratio of prestoblue in fresh dulbecco\’s modified eagle medium and incubated at 37°c for 60 minutes. the solution in each well was then transferred to a new 96-well plate and read using tecan infinite 200 pro microplate reader (tecan, m?nnedorf, switzerland) at 570 nm with a reference wavelength of 600 nm. hbmscs cultured on tissue culture plates without materials were used as a control (ctl). the results were obtained in triplicate from three separate experiments in terms of optical density. collagen and fibronectin adsorption on substrates after being cultured for different periods of time, the amounts of collagen (col) and fibronectin (fn) secreted from the cells onto the composite\’s surface were analyzed and measured using enzyme-linked immunosorbent assay. the cells were detached using a trypsin-edta solution (caisson laboratories, north logan, ut, usa) after being washed three times with cold pbs. specimens were then washed three times with pbs containing 0.1% tween-20 (pbs-t), and were then blocked with 5% bovine serum albumin (gibco) in pbs-t for 1 hour. dilutions of primary antibodies were set at 1:500. following this procedure, samples were incubated with antihuman β-actin, anti-human col i antibody or antihuman fn antibody (genetex, san antonio, tx, usa) for 3 hours at room temperature. afterwards, samples were washed three times with pbs-t for 5 minutes and incubated, while being shaken with horseradish peroxidase-conjugated secondary antibodies for 1 hour at room temperature. the samples were then washed three times with pbs-t for 10 minutes each and then one-step ultra 3,3′,5,5′-tetramethylbenzidine substrate (invitrogen) was added to the wells and developed for 30 minutes at room temperature in the dark, after which an equal volume of 2m h2so4 was added to stop and stabilize the oxidation reaction. the colored products were then transferred to new 96-well plates and read using a multiwell spectrophotometer at 450 nm with reference at 620 nm, according to the manufacturer\’s recommendations. all experiments were carried out in triplicate. additionally, β-actin antibodies were used as a control. posted in inhibitors , dopamine beta hydroxylase | no comments » mar 25 falls status having multiple falls by admin falls status (having multiple falls in the preceding 12 months compared with none or 1 fall) was significantly associated with poorer function, greater levels of pain catastrophizing and depression, lower falls efficacy, and poorer scores on the mcs (indicative of poorer mental health) for participants awaiting knee surgery. there were no significant differences on these or other measures for the group awaiting hip surgery. the smaller sample size for the group awaiting hip surgery may have contributed to the lack of significant differences between faller status groups, although the results may possibly alternatively indicate a lower impact of falls risk on these measures related to a differential impact of the severe knee joint pathology relative to severe hip joint pathology. a study on a larger sample of patients awaiting hip surgery would clarify this wnt signaling pathway issue. some of the factors shown to be significantly different between faller statuses for the knee surgery group have been shown to impact on the likely success of the planned joint replacement surgery.19 and 38 approaches to minimize risk of falls for people in milder stages of arthritis through to those approaching the stage of having surgery may help reduce the development and impact of these poor health outcomes, which may in turn result in better postoperative outcomes for these patients. falls prevention strategies including exercise that involves a moderate challenge to balance, medication review, cataract surgery, podiatric interventions (foot exercise, safe footwear), and home modifications are among approaches to falls prevention that have been shown to be effective for older people living in the community.9 however, further research is required to determine whether these approaches (e.g., exercise with a moderate challenge to balance) are feasible in people with more advanced lower limb arthritis, and whether s phase can reduce the risk of falls before surgery, reduce development of complicating factors, and potentially improve long-term outcomes with or without joint replacement surgery for people with lower limb osteoarthritis. pain is an important factor for people with arthritis, and has been shown to be associated with increased risk of falls in previous studies.39 and 40 correlation results in our study demonstrated that increased pain was significantly associated with poorer falls efficacy and increased depression. other studies have also reported that the presence of pain is also associated with higher falls efficacy scores (lower confidence in performing activities without falling).41 however, the direct mechanism by which these relationships exist are not fully understood.42 it is possible that the perception of pain and the fear of movement due to pain interfere with older adult\’s cognition, which might possibly contribute to their concerns of having a fall. however, due to the cross-sectional nature of our study we are unable to determine causality, and further research is needed to establish the nature and magnitude of this relationship. posted in inhibitors , wnt signaling pathway | no comments » mar 25 the dinoprostone insert was left in situ for hours if by admin the dinoprostone insert was left in situ for 12 hours, if possible, or removed at the onset of active labor. active labor was considered to begin when cervical dilatation was 4 cm. 6 all cases were followed by continuous electronic fetal monitoring. a partogram was drawn to follow the progress of labor. artificial rupture of membranes was done at 5-cm dilatation, and color of amniotic fluid (liquor amnii) was noted. at the 12th hour from the start of treatment, the bishop scores were re-evaluated. for patients whose bishop score was still low-dose serine protease infusion. oxytocin augmentation was applied in the second stage, if necessary. tachysystole was defined as six or more than five contractions in 10 minutes, averaged over a 30-minute window. hyperstimulation was described as a tachysystole with late fhr decelerations or fetal tachycardia (> 160 beats/min) or other worrying fhr changes.7 in the event of hyperstimulation, the vaginal dinoprostone insert was removed, and fetal resuscitation (and tocolysis, if needed) was done. non-reassuring fhr patterns were defined as persistent or recurring episodes of severe variable decelerations, late decelerations, prolonged fetal bradycardia, or a combination of decreased beat-to-beat variability and a decelerative pattern. demographic and antenatal data were collected from the delivery chart, computerized data, and patient files. the primary outcome measures were time from induction to delivery and incidence of vaginal delivery; the secondary outcomes were the caesarean section (cs) rate, side effects, rate of failed induction, the incidence of admission to the neonatal intensive care unit, and neonatal complications. all statistical analyses were performed using spss software (version 15; spss inc., chicago, il, usa). continuous data are expressed as mean (standard deviation) and were analyzed with two independent-samples tests. chi-square and fisher\’s exact tests were used for categorical data. the significance boundary (p) was given as 0.05. 3. results a total of 148 patients zone of elongation satisfied the trial criteria were recruited into the study; of these, 44 patients declined to participate, and thus 104 patients [patients with oligohydramnios (n = 40) and control patients (n = 64)] completed the study (fig. 1). the demographic variables of the patients in groups a and b are presented in table 1; age, parity, and bishop scores were insignificant between the groups (p > 0.05 for all). gestational age was significantly different between the groups (p = 0.001). figure 1 fig. 1. flowchart of study profile. figure options table 1. demographic characteristics. oligohydramnios (n = 40, 38%) control group (n = 64, 62%) p age (years) 25.55 ± 5.2 25.75 ± 5.3 ns gestational age (wk) 39.8 ± 1.03 40.7 ± 0.78 0.001* parity 1 (0–5) 1 (0–4) ns nulliparous 25 (62.5) 37 (57.8) ns posted in inhibitors , serine protease | no comments » mar 25 glutathione s-transferase v uv v uv v uv v uv v uv by admin v2679_0012_uv2 2013-08-21 01:58:29 77.60 0.20 121.20 ?83.34 v2680_0025_uv2 2013-08-22 02:49:24 80.78 0.28 123.11 ?79.81 *v2681_0004_uv2 2013-08-22 23:25:49 83.42 0.34 ?51.84 ?88.10 v2682_0025_uv2 2013-08-24 02:52:13 86.93 0.42 126.13 ?79.83 v2683_0012_uv2 2013-08-25 02:04:08 89.90 0.49 127.31 ?83.39 v2684_0025_uv2 2013-08-26 02:55:02 93.09 0.57 129.17 ?79.86 v2685_0012_uv2 2013-08-27 02:06:57 96.05 0.64 130.37 ?83.42 v2686_0025_uv2 2013-08-28 02:57:53 99.23 0.71 132.20 –79.89 v2687_0025_uv2 2013-08-29 03:00:48 102.31 0.78 133.72 ?79.79 v2688_0025_uv2 2013-08-30 02:55:43 105.37 0.85 135.20 ?80.31 v2689_0025_uv2 2013-08-31 02:57:08 108.44 0.92 136.71 ?80.32 table options 1. introduction thank\’s to the instruments on board the cassini spacecraft, orbiting the saturnian system since july 2004, for the first time it has been possible to study with continuity the glutathione s-transferase of a giant storm that erupted in saturn\’s northern hemisphere in december 2010. during the following months this storm grew zonally encircling the region between latitudes 20° n and 50° n (fletcher et al., 2011b, sánchez-lavega et al., 2011 and fischer et al., 2011). convective storms have been observed to occur regularly in the planet\’s atmosphere. however, disturbances like the one described above occur just once in a saturnian year (sánchez-lavega, 1982, sánchez-lavega et al., 1987, sánchez-lavega et al., 1991, beebe et al., 1992 and sánchez-lavega, 1994) and current models explain these phenomena as consequent to convective processes (hueso and sánchez-lavega, 2004, garcía-melendo et al., 2013 and li and ingersoll, 2015) happening after saturn\’s summer solstice (fletcher et al., 2012, sánchez-lavega et al., 2011 and sánchez-lavega, 1994). instead, the 2010 storm erupted in spring and it is the first observed at ~40° n for more than a century (fletcher et al., 2011a). the storm has been accompanied by intense lightning activity (fischer et al., 2011) and produced strong perturbations to the dynamics and the thermal structure of the stratosphere that persisted even when the disturbance weakened in july 2011 (fletcher et al., 2012). among the effects of the storm, a giant vortex formed in its wake and was observed for the first time from earth in december 2010 (sayanagi et al., 2013). atmospheric vortices have been observed at saturn since the voyager missions (smith et al., 1981, smith et al., 1982 and ingersoll et al., 1984) but thanks to cassini there is now the possibility to study them with increased temporal, spatial and spectral resolution (vasavada et al., 2006, del río-gaztelurrutia et al., 2010, sayanagi et al., 2013 and roman et al., 2013). this structure appeared to be shrinking (fletcher et al., 2012 and sayanagi et al., 2013) but we have verified that it was still present in june 2013 observations. moreover, the vortex is known to be drifting northward, transiting from a retrograde jet region toward a prograde jet one (see fig. 17 in sayanagi et al., 2013). the cloud top has been estimated quantitatively in the storm\’s head (sromovsky et al., 2013 and sánchez-lavega et al., 2011) and in its wake (sanz-requena et al., 2012), while for the clouds overlying the vortex the top pressure has been only qualitatively addressed (sánchez-lavega et al., 2012 and sayanagi et al., 2013). posted in inhibitors , glutathione s-transferase | no comments » mar 24 collectively these data highlight the importance of providing counseling to by admin collectively, these data highlight the importance of providing counseling to overweight and obese patients with psoriasis about weight loss and the impact of their weight on both psoriasis severity and treatment response (level of evidence, ib). in addition, dermatologists should be cautious of methotrexate use in obese patients with psoriasis. hypertension given the association between psoriasis and hypertension, patients with psoriasis should undergo at least standard blood pressure screening that is recommended for the general population (table ii).41 data suggest that psoriasis patients with tozadenant may have more severe hypertension42 and may be more likely to have poorly controlled blood pressure than hypertensive patients without psoriasis3; therefore, appropriate management and monitoring of blood pressure is important to emphasize. lastly, as hypertension is a well-known potential adverse effect of cyclosporine, dermatologists should use cyclosporine cautiously in patients with psoriasis who have pre-existing hypertension.43 table ii. guidelines for hypertension screening? target population screening recommendation level of evidence yes to any of the following: at increased risk for hypertension? screen annually ib level of evidence definitions: ia, evidence from metaanalysis of randomized controlled trials; ib, evidence from ≥1 randomized controlled trial; iia, evidence from ≥1 controlled study without randomization; iib, evidence from ≥1 other type of experimental study; iii, evidence from nonexperimental descriptive studies, such as comparative studies, correlation studies, and case-control studies; iv, evidence from expert committee reports or opinions or clinical experience of respected authorities, or both. data from the us preventative services task force.97 risk factors: systolic blood pressure >130-139 mm hg, diastolic blood pressure >85-89 mm hg, overweight or obese, and african american. table options diabetes as psoriasis is associated with an increased risk of diabetes, patients with psoriasis should be screened for diabetes at least according to the standard recommendations for the general population (table iii).44; 45; 46 ; 47 based on observational data that suggest more aggressive diabetes48 and greater prevalence and risk of micro- and macrovascular complications49 ; 50 among patients with than without psoriasis, it may be reasonable to consider more frequent monitoring of diabetes and screening for diabetic complications among psoriasis patients. however, additional studies are needed to support these initial findings and before such recommendations are implemented widely. table iii. guidelines for diabetes screening in asymptomatic patients? target population screening recommendation? level of evidence yes to both of the following?: level of evidence definitions: ia, evidence from metaanalysis of randomized controlled trials; ib, evidence from ≥1 randomized controlled trial; iia, evidence from ≥1 controlled study without randomization; iib, evidence from ≥1 other type of experimental study; iii, evidence from nonexperimental descriptive studies, such as comparative studies, correlation studies, and case-control studies; iv, evidence from expert committee reports or opinions or clinical experience of respected authorities, or both. posted in inhibitors , tozadenant | no comments » 12345>> blogroll ghrp 6 recent posts effect size was calculated by dividing the between as in case a the radiologist figure options the follow up period was competency in systems based practice although fruit limitations of our study included archives march 2017 february 2017 january 2017 december 2016 november 2016 october 2016 september 2016 august 2016 july 2016 june 2016 may 2016 april 2016 march 2016 february 2016 january 2016 december 2015 november 2015 october 2015 september 2015 august 2015 july 2015 june 2015 may 2015 april 2015 march 2015 february 2015 january 2015 december 2014 november 2014 october 2014 september 2014 august 2014 july 2014 june 2014 april 2014 august 2013 july 2013 june 2013 may 2013 april 2013 march 2013 february 2013 january 2013 september 2012 categories inhibitors uncategorized tags2-methoxyestradiol 3x flag peptide acth 1-39 aod9604 buy hgh frag 176-191 buy thymosin beta 4 ca 074 cjc 1293 cjc 1295 cjc 1295 with dac cjc 1295 without dac c myc peptide dsip e 64d follistatin 344 ghrp-2 ghrp 6 ha tag hexa his hexarelin hgh frag 176-191 igf 1 des igf 1 lr3 ipamorelin jq1 mechano growth factor melanotan i melanotan ii myostatin human propeptide peg mgf phos-tag phos-tag acrylamide pr-047 ps 341 pt 141 q-vd-oph sermorelin snap 8 s tag sw033291 t7 tag tb500 tesamorelin thymosin beta 4 z-vad-fmk meta log in entries rss comments rss wordpress.org © 2017 apoptosis guide theme by adazing web design


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 7487

One word

Two words phrases

Three words phrases

the - 6.38% (478)
and - 3.35% (251)
pro - 1.6% (120)
with - 1.59% (119)
for - 1.4% (105)
are - 1.02% (76)
per - 0.95% (71)
was - 0.92% (69)
her - 0.88% (66)
age - 0.84% (63)
were - 0.8% (60)
low - 0.73% (55)
all - 0.71% (53)
region - 0.61% (46)
from - 0.59% (44)
patient - 0.59% (44)
energy - 0.57% (43)
out - 0.56% (42)
efficiency - 0.47% (35)
one - 0.43% (32)
al., - 0.41% (31)
high - 0.41% (31)
2013 - 0.41% (31)
that - 0.4% (30)
end - 0.39% (29)
his - 0.37% (28)
use - 0.35% (26)
level - 0.35% (26)
our - 0.35% (26)
care - 0.35% (26)
log - 0.33% (25)
mar - 0.33% (25)
can - 0.32% (24)
patients - 0.32% (24)
study - 0.32% (24)
late - 0.31% (23)
probability - 0.31% (23)
table - 0.31% (23)
rate - 0.31% (23)
mpa - 0.29% (22)
between - 0.28% (21)
col - 0.28% (21)
this - 0.28% (21)
these - 0.27% (20)
line - 0.27% (20)
control - 0.27% (20)
des - 0.25% (19)
industry - 0.25% (19)
using - 0.24% (18)
form - 0.24% (18)
ratio - 0.24% (18)
evidence - 0.23% (17)
sawdust - 0.23% (17)
del - 0.23% (17)
may - 0.23% (17)
value - 0.23% (17)
tag - 0.21% (16)
work - 0.21% (16)
group - 0.21% (16)
china - 0.21% (16)
mental - 0.21% (16)
shift - 0.21% (16)
have - 0.21% (16)
green - 0.2% (15)
new - 0.2% (15)
time - 0.2% (15)
risk - 0.2% (15)
effect - 0.2% (15)
regional - 0.2% (15)
factor - 0.2% (15)
here - 0.2% (15)
after - 0.2% (15)
lung - 0.2% (15)
been - 0.19% (14)
studies - 0.19% (14)
when - 0.19% (14)
comments - 0.19% (14)
without - 0.19% (14)
has - 0.19% (14)
200 - 0.19% (14)
follow - 0.19% (14)
admin - 0.19% (14)
medium - 0.19% (14)
innovation - 0.19% (14)
data - 0.19% (14)
now - 0.17% (13)
tile - 0.17% (13)
ceramic - 0.17% (13)
falls - 0.17% (13)
options - 0.17% (13)
posted - 0.17% (13)
regions - 0.17% (13)
even - 0.17% (13)
each - 0.17% (13)
2015 - 0.17% (13)
more - 0.17% (13)
mode - 0.16% (12)
psoriasis - 0.16% (12)
which - 0.16% (12)
lavage - 0.16% (12)
size - 0.16% (12)
outcome - 0.16% (12)
2016 - 0.16% (12)
not - 0.16% (12)
different - 0.16% (12)
then - 0.16% (12)
increase - 0.16% (12)
than - 0.16% (12)
inhibitors - 0.16% (12)
under - 0.16% (12)
layer - 0.16% (12)
standard - 0.16% (12)
health - 0.16% (12)
thermal - 0.16% (12)
pressure - 0.15% (11)
other - 0.15% (11)
tiles - 0.15% (11)
but - 0.15% (11)
well - 0.15% (11)
approach - 0.15% (11)
show - 0.15% (11)
disease - 0.15% (11)
values - 0.15% (11)
cell - 0.15% (11)
weight - 0.15% (11)
load - 0.15% (11)
event - 0.15% (11)
used - 0.15% (11)
project - 0.15% (11)
core - 0.15% (11)
support - 0.13% (10)
period - 0.13% (10)
2010 - 0.13% (10)
conductivity - 0.13% (10)
sánchez-lavega - 0.13% (10)
who - 0.13% (10)
team - 0.13% (10)
side - 0.13% (10)
factors - 0.13% (10)
result - 0.13% (10)
score - 0.13% (10)
fig. - 0.13% (10)
surgery - 0.13% (10)
environmental - 0.13% (10)
2014 - 0.13% (10)
population - 0.13% (10)
manage - 0.13% (10)
blood - 0.13% (10)
development - 0.13% (10)
aki - 0.12% (9)
previous - 0.12% (9)
observed - 0.12% (9)
spatial - 0.12% (9)
controlled - 0.12% (9)
part - 0.12% (9)
both - 0.12% (9)
should - 0.12% (9)
while - 0.12% (9)
figure - 0.12% (9)
clinical - 0.12% (9)
hypertension - 0.12% (9)
formed - 0.12% (9)
lower - 0.12% (9)
plan - 0.12% (9)
over - 0.12% (9)
solution - 0.12% (9)
sample - 0.12% (9)
however - 0.12% (9)
national - 0.12% (9)
being - 0.12% (9)
adjacent - 0.12% (9)
sequence - 0.12% (9)
screen - 0.11% (8)
recommendation - 0.11% (8)
resource - 0.11% (8)
very - 0.11% (8)
significant - 0.11% (8)
treatment - 0.11% (8)
stem - 0.11% (8)
pap - 0.11% (8)
hip - 0.11% (8)
change - 0.11% (8)
liver - 0.11% (8)
heart - 0.11% (8)
any - 0.11% (8)
first - 0.11% (8)
trial - 0.11% (8)
based - 0.11% (8)
however, - 0.11% (8)
2011 - 0.11% (8)
year - 0.11% (8)
increased - 0.11% (8)
efficiency, - 0.11% (8)
within - 0.11% (8)
downward - 0.11% (8)
upward - 0.11% (8)
2013) - 0.11% (8)
three - 0.11% (8)
- 0.11% (8)
associated - 0.11% (8)
strength - 0.11% (8)
decrease - 0.11% (8)
through - 0.11% (8)
stoneware - 0.11% (8)
porosity - 0.11% (8)
function - 0.11% (8)
into - 0.11% (8)
its - 0.11% (8)
tube - 0.09% (7)
prevent - 0.09% (7)
complete - 0.09% (7)
present - 0.09% (7)
storm - 0.09% (7)
convergence - 0.09% (7)
club - 0.09% (7)
delivery - 0.09% (7)
light - 0.09% (7)
management - 0.09% (7)
measures - 0.09% (7)
diabetes - 0.09% (7)
area - 0.09% (7)
thus - 0.09% (7)
transfer - 0.09% (7)
will - 0.09% (7)
point - 0.09% (7)
comes - 0.09% (7)
results - 0.09% (7)
science - 0.09% (7)
discs - 0.09% (7)
pbs - 0.09% (7)
evaluate - 0.09% (7)
teamwork - 0.09% (7)
studies, - 0.09% (7)
such - 0.09% (7)
bodies - 0.09% (7)
system - 0.09% (7)
air - 0.09% (7)
exercise - 0.09% (7)
difference - 0.09% (7)
during - 0.09% (7)
content - 0.09% (7)
calculate - 0.09% (7)
scores - 0.09% (7)
main - 0.09% (7)
years - 0.09% (7)
efficiency. - 0.09% (7)
porcelain - 0.09% (7)
following - 0.09% (7)
till - 0.08% (6)
turn - 0.08% (6)
minutes - 0.08% (6)
0.05 - 0.08% (6)
lifestyle - 0.08% (6)
reduction - 0.08% (6)
higher - 0.08% (6)
calculated - 0.08% (6)
sources - 0.08% (6)
low- - 0.08% (6)
although - 0.08% (6)
pain - 0.08% (6)
body - 0.08% (6)
healthy - 0.08% (6)
ret - 0.08% (6)
se, - 0.08% (6)
2012 - 0.08% (6)
case - 0.08% (6)
10, - 0.08% (6)
multiple - 0.08% (6)
is, - 0.08% (6)
medium-high - 0.08% (6)
outcomes - 0.08% (6)
ischemic - 0.08% (6)
culture - 0.08% (6)
arm - 0.08% (6)
found - 0.08% (6)
shown - 0.08% (6)
cause - 0.08% (6)
recommendations - 0.08% (6)
human - 0.08% (6)
plate - 0.08% (6)
positive - 0.08% (6)
ia, - 0.08% (6)
status - 0.08% (6)
vascular - 0.08% (6)
general - 0.08% (6)
°c - 0.08% (6)
conservation - 0.08% (6)
mechanical - 0.08% (6)
most - 0.08% (6)
role - 0.08% (6)
july - 0.08% (6)
entity - 0.08% (6)
performed - 0.08% (6)
poor - 0.08% (6)
≥1 - 0.08% (6)
hour - 0.08% (6)
severe - 0.08% (6)
specimens - 0.08% (6)
monitoring - 0.08% (6)
product - 0.08% (6)
samples - 0.08% (6)
provide - 0.08% (6)
december - 0.08% (6)
screening - 0.08% (6)
limb - 0.07% (5)
neighbors - 0.07% (5)
bi-layered - 0.07% (5)
differences - 0.07% (5)
medication - 0.07% (5)
months - 0.07% (5)
via - 0.07% (5)
material - 0.07% (5)
impact - 0.07% (5)
saturn - 0.07% (5)
low, - 0.07% (5)
including - 0.07% (5)
medium-low - 0.07% (5)
sintered - 0.07% (5)
fluid - 0.07% (5)
volume - 0.07% (5)
incubated - 0.07% (5)
none - 0.07% (5)
guide - 0.07% (5)
foundation - 0.07% (5)
moderate - 0.07% (5)
financial - 0.07% (5)
stage - 0.07% (5)
1). - 0.07% (5)
aid - 0.07% (5)
(fletcher - 0.07% (5)
saline - 0.07% (5)
special - 0.07% (5)
conclusion - 0.07% (5)
adult - 0.07% (5)
mean - 0.07% (5)
labor - 0.07% (5)
bout - 0.07% (5)
times - 0.07% (5)
markov - 0.07% (5)
number - 0.07% (5)
incorporation - 0.07% (5)
due - 0.07% (5)
date - 0.07% (5)
open - 0.07% (5)
index - 0.07% (5)
defined - 0.07% (5)
important - 0.07% (5)
2010, - 0.07% (5)
evaluated - 0.07% (5)
according - 0.07% (5)
areas - 0.07% (5)
1999 - 0.07% (5)
process - 0.07% (5)
needed - 0.07% (5)
june - 0.07% (5)
there - 0.07% (5)
physician - 0.07% (5)
2013). - 0.07% (5)
research - 0.07% (5)
practice - 0.07% (5)
further - 0.07% (5)
sayanagi - 0.07% (5)
top - 0.07% (5)
specific - 0.07% (5)
two - 0.07% (5)
least - 0.07% (5)
usa) - 0.07% (5)
density - 0.07% (5)
participant - 0.07% (5)
apr - 0.07% (5)
bottom - 0.07% (5)
across - 0.07% (5)
before - 0.07% (5)
washed - 0.07% (5)
full-size - 0.07% (5)
people - 0.07% (5)
challenge - 0.07% (5)
cancer - 0.07% (5)
experimental - 0.07% (5)
consider - 0.07% (5)
still - 0.07% (5)
promote - 0.07% (5)
included - 0.07% (5)
also - 0.07% (5)
author - 0.07% (5)
history - 0.07% (5)
had - 0.07% (5)
porogen - 0.07% (5)
just - 0.07% (5)
described - 0.07% (5)
pore - 0.07% (5)
industries - 0.07% (5)
negative - 0.07% (5)
0.78 - 0.05% (4)
total - 0.05% (4)
older - 0.05% (4)
balance - 0.05% (4)
read - 0.05% (4)
type - 0.05% (4)
gait - 0.05% (4)
speed - 0.05% (4)
properties - 0.05% (4)
(table - 0.05% (4)
many - 0.05% (4)
obtained - 0.05% (4)
quarterback - 0.05% (4)
nurse - 0.05% (4)
anesthesia - 0.05% (4)
second - 0.05% (4)
exist - 0.05% (4)
cjc - 0.05% (4)
once - 0.05% (4)
establish - 0.05% (4)
works - 0.05% (4)
serum - 0.05% (4)
fetal - 0.05% (4)
wt% - 0.05% (4)
insert - 0.05% (4)
compare - 0.05% (4)
previously - 0.05% (4)
depend - 0.05% (4)
walking - 0.05% (4)
participants - 0.05% (4)
groups - 0.05% (4)
normal - 0.05% (4)
indicate - 0.05% (4)
left - 0.05% (4)
pbs-t - 0.05% (4)
gs-nowa - 0.05% (4)
correlation - 0.05% (4)
august - 0.05% (4)
determine - 0.05% (4)
april - 0.05% (4)
variable - 0.05% (4)
specialties - 0.05% (4)
comparison - 0.05% (4)
reduce - 0.05% (4)
peptide - 0.05% (4)
record - 0.05% (4)
oncology - 0.05% (4)
among - 0.05% (4)
analyses - 0.05% (4)
does - 0.05% (4)
stroke - 0.05% (4)
background - 0.05% (4)
introduction - 0.05% (4)
potential - 0.05% (4)
prevention - 0.05% (4)
agent - 0.05% (4)
forming - 0.05% (4)
cardiovascular - 0.05% (4)
having - 0.05% (4)
march - 0.05% (4)
large - 0.05% (4)
joint - 0.05% (4)
innovation. - 0.05% (4)
economic - 0.05% (4)
lavaged - 0.05% (4)
set - 0.05% (4)
transition - 0.05% (4)
china. - 0.05% (4)
range - 0.05% (4)
awaiting - 0.05% (4)
limited - 0.05% (4)
same - 0.05% (4)
fund - 0.05% (4)
significantly - 0.05% (4)
vitro - 0.05% (4)
beta - 0.05% (4)
like - 0.05% (4)
developed - 0.05% (4)
effects - 0.05% (4)
ckb - 0.05% (4)
pollution - 0.05% (4)
technology - 0.05% (4)
incidence - 0.05% (4)
capital - 0.05% (4)
proved - 0.05% (4)
paper - 0.05% (4)
geographical - 0.05% (4)
file - 0.05% (4)
pathway - 0.05% (4)
possible - 0.05% (4)
coronary - 0.05% (4)
january - 0.05% (4)
ib, - 0.05% (4)
baseline - 0.05% (4)
loss - 0.05% (4)
venture - 0.05% (4)
method - 0.05% (4)
ios - 0.05% (4)
arthritis - 0.05% (4)
september - 0.05% (4)
about - 0.05% (4)
acknowledge - 0.05% (4)
uncategorized - 0.05% (4)
february - 0.05% (4)
missing - 0.05% (4)
refers - 0.05% (4)
sánchez-lavega, - 0.05% (4)
committee - 0.05% (4)
whether - 0.05% (4)
effective - 0.05% (4)
their - 0.05% (4)
randomized - 0.05% (4)
features - 0.05% (4)
service - 0.05% (4)
poorer - 0.05% (4)
2017 - 0.05% (4)
37°c - 0.05% (4)
2004 - 0.04% (3)
comparative - 0.04% (3)
criteria - 0.04% (3)
center - 0.04% (3)
almost - 0.04% (3)
north - 0.04% (3)
hours - 0.04% (3)
age, - 0.04% (3)
methods - 0.04% (3)
bodies. - 0.04% (3)
definition - 0.04% (3)
urban - 0.04% (3)
efficacy - 0.04% (3)
produced - 0.04% (3)
room - 0.04% (3)
limitations - 0.04% (3)
temperature - 0.04% (3)
dinoprostone - 0.04% (3)
completed - 0.04% (3)
oxford - 0.04% (3)
rigid - 0.04% (3)
competency - 0.04% (3)
bleeding - 0.04% (3)
intrusion - 0.04% (3)
antibodies - 0.04% (3)
injury - 0.04% (3)
guidelines - 0.04% (3)
implement - 0.04% (3)
presents - 0.04% (3)
take - 0.04% (3)
populations - 0.04% (3)
work, - 0.04% (3)
since - 0.04% (3)
approaches - 0.04% (3)
(15). - 0.04% (3)
fiber - 0.04% (3)
myc - 0.04% (3)
hypertension, - 0.04% (3)
given - 0.04% (3)
whole - 0.04% (3)
mercury - 0.04% (3)
major - 0.04% (3)
fruit - 0.04% (3)
systems - 0.04% (3)
lead - 0.04% (3)
preceding - 0.04% (3)
optionsdownload - 0.04% (3)
drug - 0.04% (3)
0.5 - 0.04% (3)
cohort - 0.04% (3)
1295 - 0.04% (3)
ihd - 0.04% (3)
persist - 0.04% (3)
known - 0.04% (3)
knee - 0.04% (3)
surgery. - 0.04% (3)
combination - 0.04% (3)
bronchoscopic - 0.04% (3)
bending - 0.04% (3)
imagedownload - 0.04% (3)
powerpoint - 0.04% (3)
activity - 0.04% (3)
failure - 0.04% (3)
modifiable - 0.04% (3)
primary - 0.04% (3)
adherence - 0.04% (3)
disease; - 0.04% (3)
help - 0.04% (3)
network - 0.04% (3)
rnme - 0.04% (3)
kidney - 0.04% (3)
meanwhile, - 0.04% (3)
active - 0.04% (3)
clamped - 0.04% (3)
draining - 0.04% (3)
economy - 0.04% (3)
relationship - 0.04% (3)
filling - 0.04% (3)
application - 0.04% (3)
therefore - 0.04% (3)
meta - 0.04% (3)
lung. - 0.04% (3)
play - 0.04% (3)
complications - 0.04% (3)
additional - 0.04% (3)
composition - 0.04% (3)
medium-low, - 0.04% (3)
500 - 0.04% (3)
dea - 0.04% (3)
above - 0.04% (3)
2011) - 0.04% (3)
situ - 0.04% (3)
levels - 0.04% (3)
phenomenon - 0.04% (3)
vortex - 0.04% (3)
influenced - 0.04% (3)
ghrp - 0.04% (3)
effluent - 0.04% (3)
convergence” - 0.04% (3)
“club - 0.04% (3)
provides - 0.04% (3)
rapidly - 0.04% (3)
common - 0.04% (3)
cloud - 0.04% (3)
chinese - 0.04% (3)
occur - 0.04% (3)
introduced - 0.04% (3)
hbmscs - 0.04% (3)
instrument - 0.04% (3)
providing - 0.04% (3)
gw841819x - 0.04% (3)
matrix - 0.04% (3)
sciencell - 0.04% (3)
100% - 0.04% (3)
technical - 0.04% (3)
ensure - 0.04% (3)
less - 0.04% (3)
yes - 0.04% (3)
resources - 0.04% (3)
products - 0.04% (3)
target - 0.04% (3)
various - 0.04% (3)
highlight - 0.04% (3)
cells - 0.04% (3)
construction - 0.04% (3)
social - 0.04% (3)
obese - 0.04% (3)
simultaneous - 0.04% (3)
compared - 0.04% (3)
apoptosis - 0.04% (3)
h2o - 0.04% (3)
removed - 0.04% (3)
cultured - 0.04% (3)
sulfur - 0.04% (3)
early - 0.04% (3)
demonstrate - 0.04% (3)
protection - 0.04% (3)
industry, - 0.04% (3)
achieved - 0.04% (3)
structure - 0.04% (3)
y-tube - 0.04% (3)
systematic - 0.04% (3)
75% - 0.04% (3)
characteristics - 0.04% (3)
gs, - 0.04% (3)
bishop - 0.04% (3)
study; - 0.04% (3)
better - 0.04% (3)
dividing - 0.04% (3)
only - 0.04% (3)
demographic - 0.04% (3)
right - 0.04% (3)
radiologist - 0.04% (3)
challenges - 0.04% (3)
rigorous - 0.04% (3)
experiments - 0.04% (3)
bronchoscope - 0.04% (3)
141 - 0.04% (3)
decelerations - 0.04% (3)
fhr - 0.04% (3)
materials - 0.04% (3)
reference - 0.04% (3)
reported - 0.04% (3)
those - 0.04% (3)
similar - 0.04% (3)
proposed - 0.04% (3)
events - 0.04% (3)
established - 0.04% (3)
they - 0.04% (3)
rate, - 0.04% (3)
glutathione - 0.04% (3)
s-transferase - 0.04% (3)
dependent - 0.04% (3)
between-group - 0.04% (3)
models - 0.04% (3)
imputation - 0.04% (3)
predictive - 0.04% (3)
imputed - 0.04% (3)
november - 0.04% (3)
variables - 0.04% (3)
(1) - 0.04% (3)
october - 0.04% (3)
(2) - 0.04% (3)
continuous - 0.04% (3)
(3) - 0.04% (3)
2.1. - 0.04% (3)
causes - 0.04% (3)
physical - 0.04% (3)
tests - 0.04% (3)
containing - 0.04% (3)
recorded - 0.04% (3)
added - 0.04% (3)
spss - 0.04% (3)
function, - 0.04% (3)
observation - 0.04% (3)
ventilated - 0.04% (3)
version - 0.04% (3)
collagen - 0.03% (2)
fibronectin - 0.03% (2)
optical - 0.03% (2)
analyzed - 0.03% (2)
triplicate - 0.03% (2)
laboratories - 0.03% (2)
rss - 0.03% (2)
separate - 0.03% (2)
atmosphere - 0.03% (2)
san - 0.03% (2)
plates - 0.03% (2)
104 - 0.03% (2)
antibody - 0.03% (2)
tecan - 0.03% (2)
z-vad-fmk - 0.03% (2)
prestoblue - 0.03% (2)
assay. - 0.03% (2)
96-well - 0.03% (2)
transferred - 0.03% (2)
melanotan - 0.03% (2)
cold - 0.03% (2)
antihuman - 0.03% (2)
phos-tag - 0.03% (2)
wells - 0.03% (2)
temperature. - 0.03% (2)
buy - 0.03% (2)
secondary - 0.03% (2)
1982 - 0.03% (2)
(sánchez-lavega - 0.03% (2)
toward - 0.03% (2)
jet - 0.03% (2)
experience - 0.03% (2)
respected - 0.03% (2)
authorities, - 0.03% (2)
both. - 0.03% (2)
services - 0.03% (2)
hg, - 0.03% (2)
them - 0.03% (2)
ingersoll - 0.03% (2)
smith - 0.03% (2)
opinions - 0.03% (2)
missions - 0.03% (2)
wake - 0.03% (2)
disturbance - 0.03% (2)
strong - 0.03% (2)
1994) - 0.03% (2)
convective - 0.03% (2)
fischer - 0.03% (2)
saturn\’s - 0.03% (2)
erupted - 0.03% (2)
giant - 0.03% (2)
2004, - 0.03% (2)
collectively - 0.03% (2)
importance - 0.03% (2)
cassini - 0.03% (2)
tozadenant - 0.03% (2)
trial; - 0.03% (2)
iia, - 0.03% (2)
randomization; - 0.03% (2)
iib, - 0.03% (2)
iii, - 0.03% (2)
nonexperimental - 0.03% (2)
trials; - 0.03% (2)
metaanalysis - 0.03% (2)
definitions: - 0.03% (2)
ii. - 0.03% (2)
cyclosporine - 0.03% (2)
descriptive - 0.03% (2)
counseling - 0.03% (2)
suggest - 0.03% (2)
recommended - 0.03% (2)
undergo - 0.03% (2)
association - 0.03% (2)
case-control - 0.03% (2)
studies; - 0.03% (2)
iv, - 0.03% (2)
cautious - 0.03% (2)
dermatologists - 0.03% (2)
expert - 0.03% (2)
reports - 0.03% (2)
overweight - 0.03% (2)
saturnian - 0.03% (2)
instruments - 0.03% (2)
substrate - 0.03% (2)
replacement - 0.03% (2)
contribute - 0.03% (2)
fully - 0.03% (2)
mechanism - 0.03% (2)
direct - 0.03% (2)
activities - 0.03% (2)
improve - 0.03% (2)
arthritis, - 0.03% (2)
surgery, - 0.03% (2)
dac - 0.03% (2)
patients. - 0.03% (2)
hexa - 0.03% (2)
success - 0.03% (2)
labor. - 0.03% (2)
likely - 0.03% (2)
signaling - 0.03% (2)
wnt - 0.03% (2)
relative - 0.03% (2)
pathology - 0.03% (2)
possibly - 0.03% (2)
faller - 0.03% (2)
greater - 0.03% (2)
igf - 0.03% (2)
β-actin - 0.03% (2)
stop - 0.03% (2)
growth - 0.03% (2)
nature - 0.03% (2)
dilatation - 0.03% (2)
0.85 - 0.03% (2)
induction - 0.03% (2)
83.42 - 0.03% (2)
2013-08-22 - 0.03% (2)
0.20 - 0.03% (2)
parity - 0.03% (2)
5.3 - 0.03% (2)
5.2 - 0.03% (2)
gestational - 0.03% (2)
oligohydramnios - 0.03% (2)
software - 0.03% (2)
neonatal - 0.03% (2)
section - 0.03% (2)
decelerations, - 0.03% (2)
074 - 0.03% (2)
patterns - 0.03% (2)
vaginal - 0.03% (2)
hgh - 0.03% (2)
frag - 0.03% (2)
hyperstimulation - 0.03% (2)
tachysystole - 0.03% (2)
176-191 - 0.03% (2)
protease - 0.03% (2)
serine - 0.03% (2)
color - 0.03% (2)
thymosin - 0.03% (2)
done - 0.03% (2)
minutes. - 0.03% (2)
follow-up - 0.03% (2)
sterilized - 0.03% (2)
annual - 0.03% (2)
negatively - 0.03% (2)
0%. - 0.03% (2)
high-level - 0.03% (2)
medium-high, - 0.03% (2)
neighborhood - 0.03% (2)
backgrounds - 0.03% (2)
four - 0.03% (2)
united - 0.03% (2)
difficult - 0.03% (2)
making - 0.03% (2)
promoted - 0.03% (2)
therefore, - 0.03% (2)
rmb - 0.03% (2)
saving - 0.03% (2)
choice - 0.03% (2)
several - 0.03% (2)
reasonable - 0.03% (2)
stages - 0.03% (2)
countries - 0.03% (2)
supporting - 0.03% (2)
japan - 0.03% (2)
dioxide - 0.03% (2)
greatly - 0.03% (2)
necessary - 0.03% (2)
become - 0.03% (2)
government - 0.03% (2)
all, - 0.03% (2)
response - 0.03% (2)
change, - 0.03% (2)
inevitable - 0.03% (2)
funding - 0.03% (2)
maintain - 0.03% (2)
0.92 - 0.03% (2)
technological - 0.03% (2)
0.3) - 0.03% (2)
76% - 0.03% (2)
(for - 0.03% (2)
intensity - 0.03% (2)
exercises - 0.03% (2)
statistical - 0.03% (2)
team, - 0.03% (2)
21.0 - 0.03% (2)
ibm - 0.03% (2)
maximum - 0.03% (2)
caused - 0.03% (2)
conducted - 0.03% (2)
sequentially - 0.03% (2)
categorical - 0.03% (2)
outcomes, - 0.03% (2)
model, - 0.03% (2)
period, - 0.03% (2)
dynamic - 0.03% (2)
tested - 0.03% (2)
chain - 0.03% (2)
draw - 0.03% (2)
high. - 0.03% (2)
moreover, - 0.03% (2)
transitions - 0.03% (2)
evolution - 0.03% (2)
sensitivity - 0.03% (2)
attention - 0.03% (2)
implemented - 0.03% (2)
adjustment - 0.03% (2)
natural - 0.03% (2)
deviation - 0.03% (2)
values. - 0.03% (2)
ecological - 0.03% (2)
consumption - 0.03% (2)
sessions) - 0.03% (2)
fired - 0.03% (2)
reducing - 0.03% (2)
percolation - 0.03% (2)
consistent - 0.03% (2)
0.71 - 0.03% (2)
(from - 0.03% (2)
threefold - 0.03% (2)
decreases - 0.03% (2)
fact, - 0.03% (2)
et?al., - 0.03% (2)
lightweight - 0.03% (2)
3.2 - 0.03% (2)
required - 0.03% (2)
creates - 0.03% (2)
content. - 0.03% (2)
modulus - 0.03% (2)
attenuation - 0.03% (2)
optionsview - 0.03% (2)
home - 0.03% (2)
bulk - 0.03% (2)
characterization - 0.03% (2)
distinct - 0.03% (2)
bottom-layer - 0.03% (2)
tabletable - 0.03% (2)
workspacedownload - 0.03% (2)
young\’s - 0.03% (2)
distribution - 0.03% (2)
curves - 0.03% (2)
comply - 0.03% (2)
resistance - 0.03% (2)
degree - 0.03% (2)
discs. - 0.03% (2)
throughout - 0.03% (2)
polypropylene - 0.03% (2)
pollution. - 0.03% (2)
assistance - 0.03% (2)
waste - 0.03% (2)
advantage); - 0.03% (2)
simultaneously - 0.03% (2)
sustainable - 0.03% (2)
authors - 0.03% (2)
university - 0.03% (2)
introductionas - 0.03% (2)
time, - 0.03% (2)
real - 0.03% (2)
industries. - 0.03% (2)
non-green - 0.03% (2)
perspective - 0.03% (2)
conducive - 0.03% (2)
protection. - 0.03% (2)
below - 0.03% (2)
tiles. - 0.03% (2)
2014). - 0.03% (2)
demonstrated - 0.03% (2)
applications - 0.03% (2)
prepared - 0.03% (2)
possibility - 0.03% (2)
producing - 0.03% (2)
novel - 0.03% (2)
porosimetry - 0.03% (2)
considering - 0.03% (2)
threshold - 0.03% (2)
fast - 0.03% (2)
ceramics - 0.03% (2)
additionally, - 0.03% (2)
manufacturing - 0.03% (2)
process, - 0.03% (2)
(up - 0.03% (2)
attended - 0.03% (2)
diagnoses - 0.03% (2)
performing - 0.03% (2)
review - 0.03% (2)
alternatively - 0.03% (2)
centers - 0.03% (2)
recent - 0.03% (2)
alveoli - 0.03% (2)
oxygen - 0.03% (2)
bafilomycin - 0.03% (2)
surfactant - 0.03% (2)
alveolar - 0.03% (2)
none. - 0.03% (2)
long-term - 0.03% (2)
removal - 0.03% (2)
avoiding - 0.03% (2)
periods - 0.03% (2)
small - 0.03% (2)
adults - 0.03% (2)
fiberoptic - 0.03% (2)
biobank - 0.03% (2)
showed - 0.03% (2)
related - 0.03% (2)
50% - 0.03% (2)
white - 0.03% (2)
examine - 0.03% (2)
million - 0.03% (2)
addition, - 0.03% (2)
1.8 - 0.03% (2)
estimated - 0.03% (2)
diseases - 0.03% (2)
potentially - 0.03% (2)
participate - 0.03% (2)
study. - 0.03% (2)
approximately - 0.03% (2)
lobar - 0.03% (2)
bronchoscopy - 0.03% (2)
factors, - 0.03% (2)
inflow - 0.03% (2)
testing - 0.03% (2)
taken - 0.03% (2)
days - 0.03% (2)
static - 0.03% (2)
hydroxylase - 0.03% (2)
dopamine - 0.03% (2)
buffered - 0.03% (2)
sbf - 0.03% (2)
composites - 0.03% (2)
average - 0.03% (2)
clear. - 0.03% (2)
refill - 0.03% (2)
chest - 0.03% (2)
initial - 0.03% (2)
patient\’s - 0.03% (2)
some - 0.03% (2)
pressure, - 0.03% (2)
hypoxemia - 0.03% (2)
wll - 0.03% (2)
bll - 0.03% (2)
muscle - 0.03% (2)
relaxation - 0.03% (2)
ventilation - 0.03% (2)
repeated - 0.03% (2)
gravity - 0.03% (2)
arterial - 0.03% (2)
warm - 0.03% (2)
double - 0.03% (2)
lumen - 0.03% (2)
frequent - 0.03% (2)
lungs - 0.03% (2)
linked - 0.03% (2)
burden - 0.03% (2)
conditions - 0.03% (2)
institutions - 0.03% (2)
came - 0.03% (2)
until - 0.03% (2)
kinase - 0.03% (2)
could - 0.03% (2)
plan. - 0.03% (2)
devise - 0.03% (2)
navigator - 0.03% (2)
“right” - 0.03% (2)
sequence, - 0.03% (2)
relevant - 0.03% (2)
discipline - 0.03% (2)
facilitate - 0.03% (2)
rigorous, - 0.03% (2)
unique - 0.03% (2)
issues - 0.03% (2)
icd-9-cm - 0.03% (2)
numbers - 0.03% (2)
prescription - 0.03% (2)
habitual - 0.03% (2)
any; - 0.03% (2)
gs-nowa, - 0.03% (2)
minimum - 0.03% (2)
support. - 0.03% (2)
covariates - 0.03% (2)
teamwork, - 0.03% (2)
measurements - 0.03% (2)
available - 0.03% (2)
status. - 0.03% (2)
within- - 0.03% (2)
confidence - 0.03% (2)
referrals - 0.03% (2)
diagnosis - 0.03% (2)
codes - 0.03% (2)
kadoorie - 0.03% (2)
food - 0.03% (2)
factors: - 0.03% (2)
international - 0.03% (2)
alcohol - 0.03% (2)
dietary - 0.03% (2)
(e.g., - 0.03% (2)
approved - 0.03% (2)
namely - 0.03% (2)
confined - 0.03% (2)
strategies - 0.03% (2)
public - 0.03% (2)
electronic - 0.03% (2)
online - 0.03% (2)
data. - 0.03% (2)
files - 0.03% (2)
summation - 0.03% (2)
date. - 0.03% (2)
acute - 0.03% (2)
(tn - 0.03% (2)
12. - 0.03% (2)
creatinine - 0.03% (2)
[tp - 0.03% (2)
(tp - 0.03% (2)
fn)], - 0.03% (2)
[tn - 0.03% (2)
fp)], - 0.03% (2)
mentioned - 0.03% (2)
true - 0.03% (2)
positive, - 0.03% (2)
false - 0.03% (2)
history, - 0.03% (2)
enzyme - 0.03% (2)
claim - 0.03% (2)
design - 0.03% (2)
of the - 0.67% (50)
in the - 0.59% (44)
energy efficiency - 0.45% (34)
et al., - 0.39% (29)
to the - 0.37% (28)
and the - 0.35% (26)
the probability - 0.25% (19)
probability of - 0.23% (17)
a region - 0.2% (15)
the in - 0.2% (15)
level of - 0.19% (14)
with a - 0.19% (14)
of energy - 0.19% (14)
posted in - 0.17% (13)
by admin - 0.17% (13)
comments » - 0.17% (13)
for the - 0.16% (12)
evidence from - 0.16% (12)
» mar - 0.16% (12)
regions with - 0.15% (11)
from the - 0.15% (11)
mar 25 - 0.15% (11)
at the - 0.15% (11)
shift is - 0.15% (11)
with the - 0.13% (10)
patients with - 0.13% (10)
in inhibitors - 0.13% (10)
thermal conductivity - 0.13% (10)
no comments - 0.13% (10)
inhibitors , - 0.13% (10)
green innovation - 0.12% (9)
the follow - 0.12% (9)
adjacent to - 0.11% (8)
downward shift - 0.11% (8)
on the - 0.11% (8)
in china - 0.11% (8)
energy efficiency, - 0.11% (8)
to regions - 0.11% (8)
the thermal - 0.11% (8)
is adjacent - 0.11% (8)
upward shift - 0.11% (8)
a downward - 0.11% (8)
the care - 0.11% (8)
al., 2013 - 0.11% (8)
a high - 0.09% (7)
an upward - 0.09% (7)
have been - 0.09% (7)
energy efficiency. - 0.09% (7)
blood pressure - 0.09% (7)
efficiency, the - 0.09% (7)
care sequence - 0.09% (7)
ceramic tile - 0.09% (7)
figure options - 0.09% (7)
al., 2011 - 0.09% (7)
porcelain stoneware - 0.09% (7)
regional energy - 0.09% (7)
should be - 0.09% (7)
the region - 0.09% (7)
the patient - 0.09% (7)
from ≥1 - 0.08% (6)
the study - 0.08% (6)
green industry - 0.08% (6)
low level - 0.08% (6)
the regional - 0.08% (6)
associated with - 0.08% (6)
by the - 0.08% (6)
the following - 0.08% (6)
club convergence - 0.08% (6)
sánchez-lavega et - 0.08% (6)
with low - 0.08% (6)
sawdust content - 0.08% (6)
has been - 0.08% (6)
and environmental - 0.08% (6)
region is - 0.08% (6)
at least - 0.07% (5)
of aki - 0.07% (5)
with psoriasis - 0.07% (5)
(fletcher et - 0.07% (5)
of evidence - 0.07% (5)
high level - 0.07% (5)
when a - 0.07% (5)
table options - 0.07% (5)
risk of - 0.07% (5)
of regional - 0.07% (5)
between 1999 - 0.07% (5)
high energy - 0.07% (5)
and 2010 - 0.07% (5)
efficiency is - 0.07% (5)
sayanagi et - 0.07% (5)
efficiency in - 0.07% (5)
as the - 0.07% (5)
al., 2012 - 0.07% (5)
1999 and - 0.07% (5)
al., 2013) - 0.07% (5)
is the - 0.07% (5)
was calculated - 0.07% (5)
according to - 0.07% (5)
risk factor - 0.07% (5)
heart disease - 0.07% (5)
stoneware tiles - 0.07% (5)
the bottom - 0.07% (5)
our study - 0.07% (5)
ceramic tiles - 0.07% (5)
entity industry - 0.07% (5)
of these - 0.07% (5)
within the - 0.05% (4)
may be - 0.05% (4)
such as - 0.05% (4)
due to - 0.05% (4)
shift will - 0.05% (4)
region with - 0.05% (4)
and is - 0.05% (4)
healthy lifestyle - 0.05% (4)
times with - 0.05% (4)
conductivity of - 0.05% (4)
of our - 0.05% (4)
three times - 0.05% (4)
were used - 0.05% (4)
were then - 0.05% (4)
the ceramic - 0.05% (4)
using the - 0.05% (4)
conservation and - 0.05% (4)
using a - 0.05% (4)
and then - 0.05% (4)
sintered discs - 0.05% (4)
were performed - 0.05% (4)
lavaged lung - 0.05% (4)
the national - 0.05% (4)
speed with - 0.05% (4)
tube was - 0.05% (4)
gait speed - 0.05% (4)
the lavaged - 0.05% (4)
in this - 0.05% (4)
al., 2013). - 0.05% (4)
monitoring of - 0.05% (4)
at 37°c - 0.05% (4)
samples were - 0.05% (4)
of this - 0.05% (4)
care delivery - 0.05% (4)
and 2010, - 0.05% (4)
the 4r - 0.05% (4)
of sawdust - 0.05% (4)
with high - 0.05% (4)
washed three - 0.05% (4)
index date - 0.05% (4)
that the - 0.05% (4)
foundation of - 0.05% (4)
the index - 0.05% (4)
venture capital - 0.05% (4)
impact of - 0.05% (4)
ib, evidence - 0.05% (4)
refers to - 0.05% (4)
randomized controlled - 0.05% (4)
industry is - 0.05% (4)
based on - 0.05% (4)
shown to - 0.05% (4)
risk factors - 0.05% (4)
the first - 0.05% (4)
ia, evidence - 0.05% (4)
and may - 0.05% (4)
and sánchez-lavega - 0.05% (4)
of falls - 0.05% (4)
does not - 0.05% (4)
in table - 0.05% (4)
for people - 0.04% (3)
aki was - 0.04% (3)
in case - 0.04% (3)
and patient - 0.04% (3)
glutathione s-transferase - 0.04% (3)
used by - 0.04% (3)
the between - 0.04% (3)
gs and - 0.04% (3)
the cell - 0.04% (3)
obtained from - 0.04% (3)
11 and - 0.04% (3)
was defined - 0.04% (3)
defined as - 0.04% (3)
kidney injury - 0.04% (3)
insert was - 0.04% (3)
into the - 0.04% (3)
was left - 0.04% (3)
reduction in - 0.04% (3)
or high - 0.04% (3)
analyses were - 0.04% (3)
left in - 0.04% (3)
number of - 0.04% (3)
predictive value - 0.04% (3)
weight loss - 0.04% (3)
outcome measures - 0.04% (3)
room temperature - 0.04% (3)
the end - 0.04% (3)
limitations of - 0.04% (3)
people with - 0.04% (3)
the quarterback - 0.04% (3)
used as - 0.04% (3)
a combination - 0.04% (3)
combination of - 0.04% (3)
at room - 0.04% (3)
development of - 0.04% (3)
pbs-t for - 0.04% (3)
competency in - 0.04% (3)
been shown - 0.04% (3)
physician and - 0.04% (3)
a patient - 0.04% (3)
study included - 0.04% (3)
for each - 0.04% (3)
from a - 0.04% (3)
general anesthesia - 0.04% (3)
score was - 0.04% (3)
comparative studies - 0.04% (3)
was significantly - 0.04% (3)
of pain - 0.04% (3)
hip surgery - 0.04% (3)
and incubated - 0.04% (3)
may have - 0.04% (3)
quarterback function - 0.04% (3)
approach to - 0.04% (3)
awaiting hip - 0.04% (3)
options the - 0.04% (3)
coronary heart - 0.04% (3)
project management - 0.04% (3)
increased risk - 0.04% (3)
in oncology - 0.04% (3)
the author - 0.04% (3)
by dividing - 0.04% (3)
development and - 0.04% (3)
can be - 0.04% (3)
effect size - 0.04% (3)
matrix of - 0.04% (3)
industry refers - 0.04% (3)
resource conservation - 0.04% (3)
role in - 0.04% (3)
of green - 0.04% (3)
environmental management - 0.04% (3)
bottom layer - 0.04% (3)
use of - 0.04% (3)
uncategorized | - 0.04% (3)
same period - 0.04% (3)
meanwhile, if - 0.04% (3)
probability is - 0.04% (3)
medium-high energy - 0.04% (3)
spatial markov - 0.04% (3)
the low - 0.04% (3)
and low - 0.04% (3)
influenced by - 0.04% (3)
the radiologist - 0.04% (3)
cjc 1295 - 0.04% (3)
optionsdownload full-size - 0.04% (3)
imagedownload as - 0.04% (3)
higher than - 0.04% (3)
although fruit - 0.04% (3)
based practice - 0.04% (3)
in systems - 0.04% (3)
case a - 0.04% (3)
stoneware ceramic - 0.04% (3)
incorporation of - 0.04% (3)
full-size imagedownload - 0.04% (3)
as powerpoint - 0.04% (3)
in fig. - 0.04% (3)
added to - 0.04% (3)
layer of - 0.04% (3)
porosity level - 0.04% (3)
fig. 8 - 0.04% (3)
“club convergence” - 0.04% (3)
in uncategorized - 0.04% (3)
the storm - 0.04% (3)
and li - 0.04% (3)
the “club - 0.04% (3)
convergence” phenomenon - 0.04% (3)
which is - 0.04% (3)
study with - 0.04% (3)
and sánchez-lavega, - 0.04% (3)
geographical neighbors - 0.04% (3)
region to - 0.04% (3)
and read - 0.03% (2)
opinions or - 0.03% (2)
delivery and - 0.03% (2)
clinical experience - 0.03% (2)
of respected - 0.03% (2)
nm with - 0.03% (2)
are not - 0.03% (2)
96-well plate - 0.03% (2)
transferred to - 0.03% (2)
the results - 0.03% (2)
was then - 0.03% (2)
each well - 0.03% (2)
authorities, or - 0.03% (2)
solution in - 0.03% (2)
with an - 0.03% (2)
reports or - 0.03% (2)
for different - 0.03% (2)
in triplicate - 0.03% (2)
with pbs-t - 0.03% (2)
for 30 - 0.03% (2)
comparative studies, - 0.03% (2)
the wells - 0.03% (2)
correlation studies, - 0.03% (2)
then washed - 0.03% (2)
or more - 0.03% (2)
fischer et - 0.03% (2)
1 hour - 0.03% (2)
were washed - 0.03% (2)
and fibronectin - 0.03% (2)
room temperature. - 0.03% (2)
and case-control - 0.03% (2)
studies; iv, - 0.03% (2)
2011 and - 0.03% (2)
time from - 0.03% (2)
expert committee - 0.03% (2)
time, the - 0.03% (2)
minutes. the - 0.03% (2)
psoriasis should - 0.03% (2)
in december - 0.03% (2)
well was - 0.03% (2)
to evaluate - 0.03% (2)
beta hydroxylase - 0.03% (2)
of human - 0.03% (2)
which the - 0.03% (2)
in vitro - 0.03% (2)
evaluate the - 0.03% (2)
loss to - 0.03% (2)
beta 4 - 0.03% (2)
gestational age - 0.03% (2)
groups (p - 0.03% (2)
the groups - 0.03% (2)
the effluent - 0.03% (2)
control group - 0.03% (2)
until the - 0.03% (2)
process of - 0.03% (2)
hgh frag - 0.03% (2)
melanotan i - 0.03% (2)
was clamped - 0.03% (2)
the solution - 0.03% (2)
frag 176-191 - 0.03% (2)
with cold - 0.03% (2)
guidelines for - 0.03% (2)
incidence of - 0.03% (2)
from nonexperimental - 0.03% (2)
for diabetes - 0.03% (2)
hbmscs were - 0.03% (2)
were obtained - 0.03% (2)
the standard - 0.03% (2)
limb of - 0.03% (2)
the hbmscs - 0.03% (2)
composites were - 0.03% (2)
ghrp 6 - 0.03% (2)
performed using - 0.03% (2)
were analyzed - 0.03% (2)
oligohydramnios (n - 0.03% (2)
between the - 0.03% (2)
were incubated - 0.03% (2)
the specimens - 0.03% (2)
out of - 0.03% (2)
descriptive studies, - 0.03% (2)
antibodies were - 0.03% (2)
then transferred - 0.03% (2)
the dinoprostone - 0.03% (2)
a moderate - 0.03% (2)
these data - 0.03% (2)
to determine - 0.03% (2)
highlight the - 0.03% (2)
further research - 0.03% (2)
importance of - 0.03% (2)
moderate challenge - 0.03% (2)
providing counseling - 0.03% (2)
2011) and - 0.03% (2)
falls prevention - 0.03% (2)
the general - 0.03% (2)
population (table - 0.03% (2)
more than - 0.03% (2)
psoriasis patients - 0.03% (2)
result in - 0.03% (2)
dermatologists should - 0.03% (2)
and sayanagi - 0.03% (2)
in its - 0.03% (2)
ii. guidelines - 0.03% (2)
observed at - 0.03% (2)
its wake - 0.03% (2)
when the - 0.03% (2)
joint replacement - 0.03% (2)
and was - 0.03% (2)
of having - 0.03% (2)
outcomes with - 0.03% (2)
december 2010 - 0.03% (2)
whether s - 0.03% (2)
challenge to - 0.03% (2)
with increased - 0.03% (2)
arthritis, and - 0.03% (2)
signaling pathway - 0.03% (2)
2012 and - 0.03% (2)
lower limb - 0.03% (2)
was still - 0.03% (2)
june 2013 - 0.03% (2)
the vortex - 0.03% (2)
reduce the - 0.03% (2)
for hypertension - 0.03% (2)
iii, evidence - 0.03% (2)
≥1 controlled - 0.03% (2)
group awaiting - 0.03% (2)
trial; iia, - 0.03% (2)
compared with - 0.03% (2)
falls in - 0.03% (2)
serine protease - 0.03% (2)
falls status - 0.03% (2)
the second - 0.03% (2)
study without - 0.03% (2)
of randomized - 0.03% (2)
multiple falls - 0.03% (2)
randomization; iib, - 0.03% (2)
dopamine beta - 0.03% (2)
≥1 other - 0.03% (2)
type of - 0.03% (2)
like the - 0.03% (2)
demonstrated that - 0.03% (2)
experimental study; - 0.03% (2)
controlled trials; - 0.03% (2)
differences between - 0.03% (2)
stages of - 0.03% (2)
knee surgery - 0.03% (2)
population screening - 0.03% (2)
situ for - 0.03% (2)
active labor - 0.03% (2)
approaches to - 0.03% (2)
and 38 - 0.03% (2)
yes to - 0.03% (2)
at increased - 0.03% (2)
evidence definitions: - 0.03% (2)
faller status - 0.03% (2)
different between - 0.03% (2)
from metaanalysis - 0.03% (2)
wnt signaling - 0.03% (2)
was done - 0.03% (2)
of patients - 0.03% (2)
joint pathology - 0.03% (2)
on these - 0.03% (2)
bishop scores - 0.03% (2)
the y-tube - 0.03% (2)
apoptosis guide - 0.03% (2)
filling and - 0.03% (2)
medium-low energy - 0.03% (2)
than the - 0.03% (2)
is higher - 0.03% (2)
this probability - 0.03% (2)
maintain a - 0.03% (2)
if the - 0.03% (2)
its geographical - 0.03% (2)
provides a - 0.03% (2)
with higher - 0.03% (2)
with lower - 0.03% (2)
or medium-high - 0.03% (2)
with medium-high - 0.03% (2)
efficiency. between - 0.03% (2)
levels of - 0.03% (2)
regional neighborhood - 0.03% (2)
neighborhood with - 0.03% (2)
is within - 0.03% (2)
will increase - 0.03% (2)
regional backgrounds - 0.03% (2)
background of - 0.03% (2)
the four - 0.03% (2)
region does - 0.03% (2)
the background - 0.03% (2)
in other - 0.03% (2)
markov matrix - 0.03% (2)
technology innovation - 0.03% (2)
table 4 - 0.03% (2)
medium-low, medium-high, - 0.03% (2)
proved the - 0.03% (2)
for missing - 0.03% (2)
aid if - 0.03% (2)
habitual walking - 0.03% (2)
gs, gait - 0.03% (2)
at baseline - 0.03% (2)
of attended - 0.03% (2)
high intensity - 0.03% (2)
attended sessions) - 0.03% (2)
intensity (for - 0.03% (2)
tests were - 0.03% (2)
all statistical - 0.03% (2)
caused by - 0.03% (2)
causes for - 0.03% (2)
moreover, the - 0.03% (2)
> 0.3) - 0.03% (2)
associated (r - 0.03% (2)
ret pathway - 0.03% (2)
multiple imputation - 0.03% (2)
social science - 0.03% (2)
support of - 0.03% (2)
national social - 0.03% (2)
natural science - 0.03% (2)
the stage - 0.03% (2)
the dynamic - 0.03% (2)
by regions - 0.03% (2)
negatively influenced - 0.03% (2)
supporting role - 0.03% (2)
to promote - 0.03% (2)
without walking - 0.03% (2)
function of - 0.03% (2)
observed when - 0.03% (2)
porogen percolation - 0.03% (2)
the bi-layered - 0.03% (2)
was observed - 0.03% (2)
threefold decrease - 0.03% (2)
a standard - 0.03% (2)
as shown - 0.03% (2)
fact, the - 0.03% (2)
discs is - 0.03% (2)
layer sintered - 0.03% (2)
to those - 0.03% (2)
10 wt% - 0.03% (2)
tiles with - 0.03% (2)
sawdust content. - 0.03% (2)
young\’s modulus - 0.03% (2)
strength and - 0.03% (2)
the bottom-layer - 0.03% (2)
porosity in - 0.03% (2)
degree of - 0.03% (2)
is controlled - 0.03% (2)
mechanical resistance - 0.03% (2)
comply with - 0.03% (2)
workspacedownload as - 0.03% (2)
optionsview in - 0.03% (2)
from mercury - 0.03% (2)
sawdust incorporation - 0.03% (2)
that may - 0.03% (2)
industry and - 0.03% (2)
the authors - 0.03% (2)
new energy - 0.03% (2)
for entity - 0.03% (2)
promote green - 0.03% (2)
of financial - 0.03% (2)
sulfur dioxide - 0.03% (2)
technological innovation - 0.03% (2)
environmental protection. - 0.03% (2)
to resource - 0.03% (2)
is conducive - 0.03% (2)
the perspective - 0.03% (2)
efficiency between - 0.03% (2)
authors acknowledge - 0.03% (2)
range of - 0.03% (2)
of applications - 0.03% (2)
the range - 0.03% (2)
level is - 0.03% (2)
the product - 0.03% (2)
considering the - 0.03% (2)
by sawdust - 0.03% (2)
intrusion porosimetry - 0.03% (2)
forming agent - 0.03% (2)
a pore - 0.03% (2)
of using - 0.03% (2)
pore forming - 0.03% (2)
applications of - 0.03% (2)
any; gs-nowa, - 0.03% (2)
aid and - 0.03% (2)
during the - 0.03% (2)
university of - 0.03% (2)
the mechanical - 0.03% (2)
showed that - 0.03% (2)
the alveoli - 0.03% (2)
funding sources - 0.03% (2)
removal of - 0.03% (2)
to severe - 0.03% (2)
in our - 0.03% (2)
comparison with - 0.03% (2)
and no - 0.03% (2)
no comparison - 0.03% (2)
in previous - 0.03% (2)
completed a - 0.03% (2)
now the - 0.03% (2)
had completed - 0.03% (2)
who were - 0.03% (2)
of age - 0.03% (2)
total of - 0.03% (2)
the study. - 0.03% (2)
age were - 0.03% (2)
years of - 0.03% (2)
the ckb - 0.03% (2)
in addition, - 0.03% (2)
china kadoorie - 0.03% (2)
a large - 0.03% (2)
lifestyle factors - 0.03% (2)
lung lavage - 0.03% (2)
choice for - 0.03% (2)
has become - 0.03% (2)
both lungs - 0.03% (2)
was performed - 0.03% (2)
to low - 0.03% (2)
lavaged lung. - 0.03% (2)
effluent fluid - 0.03% (2)
y-tube was - 0.03% (2)
inflow limb - 0.03% (2)
the patient\’s - 0.03% (2)
by gravity - 0.03% (2)
saline solution - 0.03% (2)
of both - 0.03% (2)
the tube - 0.03% (2)
double lumen - 0.03% (2)
bronchoscopic lobar - 0.03% (2)
whole lung - 0.03% (2)
normal saline - 0.03% (2)
rigid bronchoscope - 0.03% (2)
arterial blood - 0.03% (2)
blood pressure, - 0.03% (2)
heart rate, - 0.03% (2)
with standard - 0.03% (2)
muscle relaxation - 0.03% (2)
lavage under - 0.03% (2)
the rigid - 0.03% (2)
that of - 0.03% (2)
bronchoscopy under - 0.03% (2)
is known - 0.03% (2)
ischemic stroke - 0.03% (2)
with minimum - 0.03% (2)
is established - 0.03% (2)
the acute - 0.03% (2)
positive predictive - 0.03% (2)
outcome of - 0.03% (2)
up period - 0.03% (2)
clinical trial - 0.03% (2)
patient care - 0.03% (2)
devise the - 0.03% (2)
the “right” - 0.03% (2)
the nurse - 0.03% (2)
clinical recommendations - 0.03% (2)
the process - 0.03% (2)
care project - 0.03% (2)
in serum - 0.03% (2)
to many - 0.03% (2)
work and - 0.03% (2)
and it - 0.03% (2)
or health - 0.03% (2)
issues are - 0.03% (2)
cancer patient - 0.03% (2)
referrals to - 0.03% (2)
pathway | - 0.03% (2)
between-group differences - 0.03% (2)
better status. - 0.03% (2)
scores indicate - 0.03% (2)
indicate better - 0.03% (2)
network criteria - 0.03% (2)
creatinine of - 0.03% (2)
ischemic heart - 0.03% (2)
confined to - 0.03% (2)
heart disease; - 0.03% (2)
online data - 0.03% (2)
weight and - 0.03% (2)
practice although - 0.03% (2)
systems based - 0.03% (2)
s6 kinase - 0.03% (2)
summation of - 0.03% (2)
years or - 0.03% (2)
following risk - 0.03% (2)
the summation - 0.03% (2)
(15). the - 0.03% (2)
bulk density - 0.03% (2)
history was - 0.03% (2)
increase in - 0.03% (2)
preceding the - 0.03% (2)
3 months - 0.03% (2)
least 1 - 0.03% (2)
was confined - 0.03% (2)
medication history - 0.03% (2)
index date. - 0.03% (2)
to any - 0.03% (2)
is false - 0.03% (2)
is true - 0.03% (2)
+ fp)], - 0.03% (2)
+ fn)], - 0.03% (2)
serum creatinine - 0.03% (2)
thymosin beta - 0.03% (2)
the probability of - 0.23% (17)
probability of a - 0.21% (16)
of energy efficiency - 0.17% (13)
comments » mar - 0.16% (12)
» mar 25 - 0.15% (11)
posted in inhibitors - 0.13% (10)
| no comments - 0.13% (10)
no comments » - 0.13% (10)
in inhibitors , - 0.13% (10)
level of energy - 0.12% (9)
to regions with - 0.11% (8)
adjacent to regions - 0.11% (8)
a downward shift - 0.11% (8)
of a downward - 0.11% (8)
et al., 2013 - 0.11% (8)
is adjacent to - 0.11% (8)
an upward shift - 0.09% (7)
if a region - 0.09% (7)
of an upward - 0.09% (7)
energy efficiency, the - 0.09% (7)
probability of an - 0.09% (7)
the care sequence - 0.08% (6)
regional energy efficiency - 0.08% (6)
sánchez-lavega et al., - 0.08% (6)
evidence from ≥1 - 0.08% (6)
and the probability - 0.08% (6)
a region is - 0.08% (6)
efficiency, the probability - 0.08% (6)
downward shift is - 0.08% (6)
the thermal conductivity - 0.08% (6)
low level of - 0.07% (5)
a low level - 0.07% (5)
(fletcher et al., - 0.07% (5)
between 1999 and - 0.07% (5)
energy efficiency is - 0.07% (5)
energy efficiency in - 0.07% (5)
sayanagi et al., - 0.07% (5)
upward shift is - 0.07% (5)
patients with psoriasis - 0.07% (5)
of energy efficiency. - 0.07% (5)
et al., 2012 - 0.07% (5)
according to the - 0.07% (5)
level of evidence - 0.07% (5)
a high level - 0.07% (5)
region is adjacent - 0.05% (4)
high level of - 0.05% (4)
in the bottom - 0.05% (4)
the lavaged lung - 0.05% (4)
of the following - 0.05% (4)
efficiency is adjacent - 0.05% (4)
porcelain stoneware tiles - 0.05% (4)
1999 and 2010, - 0.05% (4)
gait speed with - 0.05% (4)
ia, evidence from - 0.05% (4)
washed three times - 0.05% (4)
of our study - 0.05% (4)
the index date - 0.05% (4)
thermal conductivity of - 0.05% (4)
of a region - 0.05% (4)
conservation and environmental - 0.05% (4)
ib, evidence from - 0.05% (4)
in case a - 0.04% (3)
al., 2013 and - 0.04% (3)
by dividing the - 0.04% (3)
size was calculated - 0.04% (3)
dividing the between - 0.04% (3)
“club convergence” phenomenon - 0.04% (3)
was calculated by - 0.04% (3)
science foundation of - 0.04% (3)
dinoprostone insert was - 0.04% (3)
a combination of - 0.04% (3)
regions with a - 0.04% (3)
with a high - 0.04% (3)
figure options the - 0.04% (3)
full-size imagedownload as - 0.04% (3)
et al., 2011) - 0.04% (3)
our study included - 0.04% (3)
competency in systems - 0.04% (3)
in uncategorized | - 0.04% (3)
options the follow - 0.04% (3)
calculated by dividing - 0.04% (3)
optionsdownload full-size imagedownload - 0.04% (3)
effect size was - 0.04% (3)
layer of the - 0.04% (3)
were used as - 0.04% (3)
at room temperature - 0.04% (3)
under general anesthesia - 0.04% (3)
and environmental protection - 0.04% (3)
of green innovation - 0.04% (3)
and environmental management - 0.04% (3)
industry refers to - 0.04% (3)
limitations of our - 0.04% (3)
shown to be - 0.04% (3)
meanwhile, if a - 0.04% (3)
when a region - 0.04% (3)
coronary heart disease - 0.04% (3)
been shown to - 0.04% (3)
be associated with - 0.03% (2)
further research is - 0.03% (2)
increased risk of - 0.03% (2)
then washed three - 0.03% (2)
new 96-well plate - 0.03% (2)
and read using - 0.03% (2)
well was then - 0.03% (2)
at room temperature. - 0.03% (2)
with pbs-t for - 0.03% (2)
for 1 hour - 0.03% (2)
in its wake - 0.03% (2)
times with pbs-t - 0.03% (2)
al., 2011 and - 0.03% (2)
left in situ - 0.03% (2)
added to the - 0.03% (2)
for 30 minutes - 0.03% (2)
was significantly associated - 0.03% (2)
then transferred to - 0.03% (2)
used as a - 0.03% (2)
a moderate challenge - 0.03% (2)
for people with - 0.03% (2)
associated with poorer - 0.03% (2)
oligohydramnios (n = - 0.03% (2)
group awaiting hip - 0.03% (2)
between the groups - 0.03% (2)
the group awaiting - 0.03% (2)
for the first - 0.03% (2)
study without randomization; - 0.03% (2)
in december 2010 - 0.03% (2)
other type of - 0.03% (2)
respected authorities, or - 0.03% (2)
for the general - 0.03% (2)
of evidence yes - 0.03% (2)
of evidence definitions: - 0.03% (2)
metaanalysis of randomized - 0.03% (2)
controlled trials; ib, - 0.03% (2)
randomized controlled trial; - 0.03% (2)
iia, evidence from - 0.03% (2)
≥1 controlled study - 0.03% (2)
without randomization; iib, - 0.03% (2)
experimental study; iii, - 0.03% (2)
or opinions or - 0.03% (2)
evidence from nonexperimental - 0.03% (2)
descriptive studies, such - 0.03% (2)
as comparative studies, - 0.03% (2)
correlation studies, and - 0.03% (2)
case-control studies; iv, - 0.03% (2)
evidence from expert - 0.03% (2)
committee reports or - 0.03% (2)
opinions or clinical - 0.03% (2)
experience of respected - 0.03% (2)
authorities, or both. - 0.03% (2)
up period was - 0.03% (2)
clinical experience of - 0.03% (2)
expert committee reports - 0.03% (2)
have been observed - 0.03% (2)
randomized controlled trials; - 0.03% (2)
and sayanagi et - 0.03% (2)
these data highlight - 0.03% (2)
the importance of - 0.03% (2)
providing counseling to - 0.03% (2)
obese patients with - 0.03% (2)
the general population - 0.03% (2)
target population screening - 0.03% (2)
evidence yes to - 0.03% (2)
definitions: ia, evidence - 0.03% (2)
from metaanalysis of - 0.03% (2)
≥1 randomized controlled - 0.03% (2)
iv, evidence from - 0.03% (2)
trial; iia, evidence - 0.03% (2)
from ≥1 controlled - 0.03% (2)
and incubated at - 0.03% (2)
iib, evidence from - 0.03% (2)
≥1 other type - 0.03% (2)
of experimental study; - 0.03% (2)
iii, evidence from - 0.03% (2)
nonexperimental descriptive studies, - 0.03% (2)
such as comparative - 0.03% (2)
studies, correlation studies, - 0.03% (2)
and case-control studies; - 0.03% (2)
end of the - 0.03% (2)
tabletable optionsview in - 0.03% (2)
the hbmscs were - 0.03% (2)
to maintain a - 0.03% (2)
is within the - 0.03% (2)
regional neighborhood with - 0.03% (2)
with low energy - 0.03% (2)
medium-high energy efficiency, - 0.03% (2)
regions with high - 0.03% (2)
or medium-high energy - 0.03% (2)
energy efficiency. between - 0.03% (2)
region to maintain - 0.03% (2)
probability is higher - 0.03% (2)
than the probability - 0.03% (2)
this probability is - 0.03% (2)
shift will increase - 0.03% (2)
higher than the - 0.03% (2)
influenced by regions - 0.03% (2)
negatively influenced by - 0.03% (2)
of the national - 0.03% (2)
natural science foundation - 0.03% (2)
and the national - 0.03% (2)
the national social - 0.03% (2)
(r > 0.3) - 0.03% (2)
> 0.3) with - 0.03% (2)
when caused by - 0.03% (2)
shift will decrease - 0.03% (2)
role in the - 0.03% (2)
habitual walking aid - 0.03% (2)
as a pore - 0.03% (2)
in the bottom-layer - 0.03% (2)
the incorporation of - 0.03% (2)
bending strength and - 0.03% (2)
layer sintered discs - 0.03% (2)
conductivity of the - 0.03% (2)
of a standard - 0.03% (2)
threefold decrease in - 0.03% (2)
thermal conductivity attenuation - 0.03% (2)
ceramic tiles with - 0.03% (2)
range of applications - 0.03% (2)
mercury intrusion porosimetry - 0.03% (2)
it is the - 0.03% (2)
is controlled by - 0.03% (2)
incorporation of sawdust - 0.03% (2)
porogen percolation threshold - 0.03% (2)
decrease in the - 0.03% (2)
matrix of regional - 0.03% (2)
to resource conservation - 0.03% (2)
and environmental protection. - 0.03% (2)
green industry is - 0.03% (2)
conducive to resource - 0.03% (2)
to promote green - 0.03% (2)
of green innovation. - 0.03% (2)
high intensity (for - 0.03% (2)
if any; gs-nowa, - 0.03% (2)
at 37°c in - 0.03% (2)
standard monitoring of - 0.03% (2)
a healthy lifestyle - 0.03% (2)
has become a - 0.03% (2)
of age were - 0.03% (2)
the ckb cohort - 0.03% (2)
no comparison with - 0.03% (2)
whole lung lavage - 0.03% (2)
lavage under general - 0.03% (2)
ventilation with standard - 0.03% (2)
monitoring of heart - 0.03% (2)
rate, blood pressure, - 0.03% (2)
heart rate, blood - 0.03% (2)
following risk factors - 0.03% (2)
the y-tube was - 0.03% (2)
of the lavaged - 0.03% (2)
the lavaged lung. - 0.03% (2)
at the end - 0.03% (2)
limb of the - 0.03% (2)
y-tube was clamped - 0.03% (2)
to evaluate the - 0.03% (2)
dopamine beta hydroxylase - 0.03% (2)
the solution in - 0.03% (2)
point for each - 0.03% (2)
based practice although - 0.03% (2)
summation of the - 0.03% (2)
gait speed without - 0.03% (2)
the development of - 0.03% (2)
walking aid and - 0.03% (2)
with minimum support. - 0.03% (2)
scores indicate better - 0.03% (2)
speed with habitual - 0.03% (2)
walking aid if - 0.03% (2)
any; gs-nowa, gait - 0.03% (2)
speed without walking - 0.03% (2)
aid and with - 0.03% (2)
the 4r approach - 0.03% (2)
teamwork in oncology - 0.03% (2)
of the care - 0.03% (2)
score was calculated - 0.03% (2)
follow up period - 0.03% (2)
was defined as - 0.03% (2)
based on the - 0.03% (2)
acute kidney injury - 0.03% (2)
kidney injury network - 0.03% (2)
serum creatinine of - 0.03% (2)
[tp / (tp - 0.03% (2)
positive predictive value - 0.03% (2)
the index date. - 0.03% (2)
history was confined - 0.03% (2)
months preceding the - 0.03% (2)
was confined to - 0.03% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.